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Preface 
This is a thesis with publications. While chapters 1 and 6 are the Introduction and 
Conclusion respectively, chapters 2-5 encompass the main body of work done. Chapters 
2 and 3 have already been published. Chapters 4 and 5 are also presented in the form of 
manuscripts as we intend to publish them. At the time of submission of this thesis, 
chapter 4 is under peer review. The published chapters are reproduced here verbatim 
with only formatting changes done so they fit in with the larger body of work. 
With the chapters being presented in the form of manuscripts, they have their own 
Abstracts, Introduction, Materials and methods, Results and Discussion sections. 
Although care was taken to not be repetitive in the Introduction and Discussion chapters 
of the thesis, some overlap was inevitable. 
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Abstract 
Chikungunya virus (CHIKV) of Alphavirus genus, has caused several outbreaks around 
the world in the last decade. Once a relatively unknown virus, it now causes seasonal 
infections in tropical and some temperate regions. This change in epidemiology is 
attributed to vector switch from Aedes aegypti to Aedes albopictus, an invasive pest leading 
to infections in temperate regions. Although recent research has identified mosquito 
factors influencing infections, our understanding of interaction between CHIKV and its 
new vector is limited.  
Using whole transcriptome sequencing of CHIKV infected mosquitoes, we studied 
differential expression of genes in the midgut and head and thorax, the two critical barrier 
sites of the mosquito at two time points. We identified several up and down regulated 
transcripts in the mosquito host genome in response to the viral infection. Two days post-
infection, in the midgut tissue of the mosquitoes, 250 differentially expressed transcripts 
(25 when the next-generation sequencing (NGS) reads were aligned to the published 
reference genome and 225 when the reads were aligned to a de novo custom 
transcriptome we generated) were identified. From the head and thorax tissue of the 
mosquitoes, 8 days post-infection, 159 differentially expressed transcripts (96 when the 
NGS reads were aligned to the published reference genome and 63 when the reads were 
aligned to the de novo custom transcriptome) were identified. Twenty-seven of the 
targets (13 from 2dpi/midgut and 14 from 8dpi/head & thorax) identified to be 
differentially expressed were validated separately via qRT-PCR. Seven transcripts found 
to be differentially expressed in midguts of Ae. albopictus two days post-infection were 
also assessed for changes in expression in midguts of Ae. aegypti two days post-infection. 
Apart from differential expression in genes, we also identified down regulation of long 
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non-coding RNAs that may also have functional relevance. The comparison between Ae. 
albopictus and Ae. aegypti also showed that the expression patterns of the same targets are 
different between the two species of mosquitoes after CHIKV infection. 
From the targets we validated, two were selected for further functional studies. Niemann-
Pick 2 (NPC2) gene homologue was found to be significantly upregulated in the midguts 
of both Ae. albopictus and Ae. aegypti mosquitoes, two days post-infection with CHIKV. 
Known cytoplasmic lipid transporters, NPC family proteins had previously been 
implicated in pathogenesis of several viruses including dengue, Ebola and HIV. In fact, 
NPC2 protein was found to be essential for successful replication of CHIKV in human 
fibroblasts. To characterise the role of NPC2 during CHIKV in Ae. albopictus mosquito, 
the gene was over expressed in C6/36 mosquito cells 24 hours prior infection with the 
virus. The infectivity titres of extracellular mature virus and intracellular viral RNA levels 
were compared between wildtype cells and cells over expressing the protein. The 
expressed NPC2 protein and the virus were also labelled using antibodies and studied 
under confocal microscopy. While significant differences were not observed in the viral 
RNA levels or infectivity titres, confocal microscopy showed partial co-localisation of 
NPC2 protein and the virus. 
Inhibitor of Bruton’s tyrosine kinase (BTKi) was identified to be significantly upregulated 8 
days post-infection in the head and thorax of Ae. albopictus mosquitoes. To assess its 
functional significance, BTKi was knocked-down using double-stranded RNA in RML12, 
a mosquito cell line. While no significant difference in viral RNA levels or infectivity titers 
was detected, BTKi gene knocked-down cells showed increased apoptosis 24 hours post-
infection compared with control cells, suggesting involvement of BTKi in the mosquito 
response to viral infection. BTK is a pro-inflammatory cytoplasmic Tec kinase and is 
known to be involved in osteoclastogenesis, a hallmark of CHIKV pathogenesis. The 
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upregulation of BTKi a known anti-inflammatory protein post viral infection and increase 
in cellular apoptosis when the gene is knocked down may suggest a possible conserved 
mechanism at play between mosquitoes and mammals. 
We also studied changes in the viral genome during mosquito infection. We detected 
changes in viral diversity, as shown by number of mutations in the viral genome, with 
increase in number of mutations in the midgut compared with mammalian host (Vero 
cell culture), followed by reduction in the number of mutations in head and thorax at 8 
dpi, indicating a possible genomic bottleneck.  
Taken together, these results will help in understanding Ae. albopictus interactions with 
CHIKV and can lead to development of novel disease control strategies.  
  
4 
 
 
 
 
 
 
 
 
Chapter-1  
Introduction 
   
5 
 
Chapter 1: Introduction 
1.1 Chikungunya Virus 
Chikungunya virus (CHIKV) was first identified and described as an independent virus 
in 1955, in a report on an outbreak at the border of Tanzania and Mozambique in 1952. 
While the virus was partially isolated, complete isolation and characterisation was 
completed after an outbreak in Vellore, Southern India in 1964. The name chikungunya 
is believed to have been derived from the word “Kungunyala” of the local “Makonde” 
language roughly translating into “to bend”. Prior to being named Chikungunya, the 
viral affliction was also called “Kidinga pepo”, meaning “a disease characterised by a 
sudden cramp-like seizure, caused by an evil spirit” in Swahili (1-3). 
Chikungunya virus is an enveloped, positive sense RNA virus (Baltimore classification: 
Class-IV) belonging to the Alphavirus genus in Togaviridae family. The viruses in 
Alphavirus genus are classified based on their geographical distribution into old world 
(Sindbis and Semliki forest group) and new world viruses (VWE-EEV group) (Table 1.1). 
Most alphaviruses are arboviruses, with a life cycle that involves a vertebrate host and 
hematophagous arthropod vectors. Interestingly the clinical diseases caused by these 
viruses also follow this geographic stratification. Old world viral infections cause high 
febrile illness, cutaneous exanthema and debilitating and often prolonged arthralgia 
while the new world viral infections typically cause equine and human encephalitic 
disease (4, 5).  
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Table 1.1 Classification of Alphavirus 
Alphavirus 
Old world New world 
Sindbis group Semliki forest group VWE-EEV group 
Sindbis virus Semliki forest virus Venezuelan equine encephalitis virus 
  Chikungunya virus Eastern equine encephalitis virus 
  Barmah Forest virus Western equine encephalitis virus 
  Ross River virus  
  O'nyong'nyong virus  
  Una virus   
It is also now accepted that what is now called chikungunya was the original classical 
dengue and what is now called dengue is what was originally called the “Breakbone 
fever”. Lack of serological and molecular diagnostic methods and similarity in clinical 
symptoms of chikungunya and dengue led to this confusion. It is now clear that while 
the onset and early symptoms of both the diseases are similar, arthralgia and arthritis 
associated with chikungunya tend to endure for much longer periods, sometimes months 
(6).  
Historically, David Bylon, a Dutch municipal surgeon, working in Jakarta, Indonesia was 
credited with recording the first outbreak in 1779 (7). Epidemiological observations and 
studying of recordings of various disease outbreaks show that periodic outbreaks of 
chikungunya have been occurring approximately every 40 years, in 1770s, 1824, 1871, 
1902, 1923, and 1963. These outbreaks started in eastern Africa and spread across towards 
South-East Asia crossing over the Indian Ocean regions including India, Sri Lanka, 
Burma and islands of the region like Madagascar, Mauritius, except for the one recorded 
outbreak in 1827-28 in the Caribbean islands (8). This outbreak is believed to be an 
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extension of the 1824 outbreak in Zanzibar, Africa, which spread in both east and west 
directions. In this outbreak, considered to be the last one in the Americas before 2005, 
about 12000 cases were recorded. The most recent outbreak (2005-ongoing), occurring 
after ~40 years after the last outbreak in 1963, has also spread around the world (8). 
The current and ongoing chikungunya outbreak is the biggest yet, both in terms of the 
duration of the outbreak and the number of people infected. Starting in the French La 
Reunion Islands in 2005 where over 244,000 (about 50% of the population) cases were 
recorded with 203 deaths (mortality: 0.08%) (9, 10). The outbreak then spread to other 
regions including the Indian subcontinent. During the 2005-2006 outbreak in India, over 
a million cases were diagnosed (11).  Since then chikungunya disease has become 
seasonal and endemic with regular outbreaks in multiple Asian, African and American 
regions. While the Reunion Islands were where the first large scale infections was 
recorded, this outbreak is also believed to have started in East Africa. Chikungunya 
infections have also been recorded in Europe with cases in Italy, France and Spain (12-
14). Current geographic distribution of CHIKV is presented in Figure 1.1. 
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 Figure 1.1 Geographic distribution of Chikungunya (as of 17th September 2019, local transmissions 
only)(15) 
1.2 Virology & Chikungunya Disease 
The chikungunya virion is ~70nm in diameter. The viral genome is surrounded by a 
capsid protein shell surrounded by a host derived lipid envelope with glycoprotein 
spikes. Both the capsid shell and the protein spikes (heterodimers of E1 and E2 proteins) 
are arranged in T=4 lattice. 80 spikes are arranged as trimers of heterodimers per virion 
particle while 240 individual proteins form a single capsid unit (16-19)(Figure 1.2). 
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Figure 1.2: Alphaviral Virion Structure (18, 19) 
The single stranded, positive sense RNA genome is about 11-12 kb in length with two 
open reading frames (ORFs) that code for two polyproteins, one structural and one non-
structural. The viral genome is capped (5’) and polyadenylated (3’). Virion RNA is 
infectious and acts as both genomic and mRNA. During early stages of infection, the 
genome is translated into a non-structural polyprotein (P123) which is processed and 
cleaved by a combination of both viral and host proteases. P123 is cleaved into NSP1, 
NSP2 (Viral protease) and NSP3. NSP4 or RNA dependent RNA polymerase (RdRp) is 
expressed by suppression of termination at the 3’ end of the nonstructural polyproteins. 
These nonstructural proteins help further establish the infection through viral genome 
replication. In later stages of infection, structural polyproteins are expressed through sub-
genomic mRNA transcription (16-19).  
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Figure 1.3: Schematic representation of Chikungunya viral genome organization (18, 19) 
A Downstream Hairpin Loop (DLP) close to the 5’ region of the sub-genomic structural 
protein coding ORF aids in inhibition of translation shut off via host Protein Kinase R 
pathways. The structural polyprotein is expressed in late stages of infection through 
promotion of sub-genomic mRNA translation. As with non-structural proteins, the 
polyprotein is cleaved into functional individual proteins by a combination of viral and 
host proteolytic activity. Ribosomal frameshifting at the 6K region results in the 
translation of the TF protein (Figure 1.3) (16-19). 
Chikungunya viral fever is characterised with sudden onset febrile illness lasting for 
about a week often with poor response to antipyretic treatments, musculoskeletal joint 
pains and headache. Fatigue, anorexia and nausea are common. Peripheral joints 
including knees and elbows are heavily inflamed with effusions. Different cutaneous 
changes are also observed in over 50% of patients. While the symptoms become tolerable 
after the first week, there are high chances of relapse (20). 
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While not commonly fatal, critical complications of central nervous system following 
CHIKV infections have been observed. The symptoms are interesting in that they are 
similar to the symptoms of diseases caused by the “New world” alphaviruses (21). 
Chikungunya viral disease in humans is a two-stage condition. The first ten days of 
CHIKV infection is defined as the acute state of infection followed by a chronic phase. A 
small proportion of infections remain asymptomatic, usually less than 10%. Mother to 
child vertical transmission has been noted in near term viremic mothers. About 50% of 
the children born in this condition were infected, often with central nervous system 
complications and poor prognosis. Unlike Zika infection, malformations or 
developmental deformities including megalocephaly are not observed in CHIKV 
infections of pregnant women. The risk of miscarriage was higher before the 22nd week of 
pregnancy (22-25).  
Chronic stage of infection is observed as rebound symptoms post the initial 
improvement, signified by prolonged rheumatism and reduced quality of life. The 
symptoms were worse in patients with pre-existing complications including cardiac and 
arthritic issues, progressive age and obesity (26). CHIKV-induced rheumatism is the most 
frequent manifestation of the chronic stage. It consists of three clinical components, singly 
or in combination: 1) distal polyarthritis or monoarthritis mildly improved with non-
steroid anti-inflammatory drugs, 2) frequent tenosynovitides in the hands, wrists, or 
ankles, highly sensitive to short-term systemic cortico-therapy, and 3) exacerbation of 
pain in previously injured joints and bones requiring painkillers. Rebound symptoms 
have been observed years after original infection and significantly affect lifestyle of 
patients. No effective vaccines are available, and treatment is mostly symptomatic with 
painkillers and NSAIDs for relief from pain (27-29). 
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1.3 Vectors 
Mosquitoes belonging to the Aedes genus of the Culicine family have been known to be 
competent vectors for several arboviruses (30). Ae. aegypti had been the traditional 
classical vector for CHIKV. While other species of the Aedes genus have also been 
competent vectors of the virus, their utility in the wild has not been clearly studied (31, 
32). Since the Reunion Island outbreak, Ae. albopictus has been observed to be more 
involved in viral transmission. Research showed that a single mutation in codon 226 of 
the E1 gene of the viral genome, improved fitness of CHIKV in Ae. albopictus. This genetic 
shift has been implicated for most of the recent outbreaks where despite absence of the 
traditional vector Ae. aegypti, CHIKV has successfully established infections through Ae. 
albopictus (33). 
Ae. aegypti, also called Yellow Fever mosquito, is a known vector for transmitting a wide 
variety of arboviruses including yellow fever, chikungunya, dengue and Zika. 
Originating in Africa, they have now spread to most tropical and subtropical regions of 
the world on all continents (34-36). The males feed on sugars from flower nectar while 
the females need both sugar for growth and protein from blood for egg laying. While 
capable of feeding at all times, preference is observed to be between dawn and dusk. The 
average life span is two to four weeks and eggs can stay viable for a long time (up to a 
year) thus allowing repopulation of an area after particularly long adverse seasons. Ae. 
aegypti has evolved into an urban dweller, preferring to live in close proximity to human 
settlements. Egg laying happens in stagnant but clean (non-muddy) waters around 
human habitats such as rain water trapped in waste bottles and barrels (37). 
Ae. albopictus, also called Asian tiger mosquito, is an invasive pest (38). It is capable of 
acting as a vector to most arboviruses transmitted by Ae. aegypti including some parasitic 
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nematodes. True to its nature of being an invasive species, Ae. albopictus has been 
expanding its traditional habitat of tropical and sub-tropical regions to much cooler 
temperate regions (39). While they stay active yearlong in the warm tropical regions, they 
have been observed to undergo hibernation during winter. Adult Ae. albopictus 
mosquitoes have also been noted to survive in favourable microhabitats even in winter 
and freezing temperatures (40). 
It is now believed that the mosquitoes reached North America through used auto tire 
trade from Asia and spread rapidly, establishing themselves and thrived (41). In 
Australia, while Ae. aegypti is well entrenched in Australian mainland, Ae. albopictus 
mosquitoes are only endemic to Torres strait island (42, 43). While CHIKV is not endemic 
to Australia, Barmah Forest virus (BFV) and Ross River virus (RRV) are endemic 
alphaviruses and cause routine infections. The symptoms caused are similar to other old 
world alphaviral diseases (44). Multiple vertebrates in Australia show antibodies to both 
BFV and RRV (45).  
While several human chikungunya cases have been diagnosed in mainland Australia, 
these are all in travellers returning from CHIKV endemic areas and infected overseas (46). 
CHIKV is not endemic to Australia as of now, but it is clear that it is only a matter of time 
before the virus spreads in Australia. Competent vectors (in particular Ae. albopictus), a 
known pest is slowly but surely spreading their footprint. With ever increasing global 
travelling, global warming and explosion of population, an effective multipronged 
approach to tackle this fast approaching problem is needed to control the mosquito 
numbers and thus diminish the chances of not just CHIKV becoming endemic but 
prevent/eradicate RRV and BFV infections.  
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1.4 Viral Transmission 
Female mosquitoes require protein for oogenesis. This protein need is met through blood 
feeding from warm blooded animals, which exposes them to a variety of blood borne 
pathogens. While not every pathogen is adapted to survive the digestive system of 
mosquitoes, infect the cells, replicate and establish infections, several arboviruses have 
(47, 48). The virus enters and replicates in the midgut epithelium and disseminates 
further into the haemocoel and then makes its way to the salivary glands of the mosquito, 
which are present in the top 1/3rd thorax region (49). Once the salivary glands of the 
mosquitoes are infected, virus is usually found in the saliva of the mosquito (50-53). At 
this stage the mosquito is considered infective. When a female mosquito bites an 
organism for blood feeding, saliva is injected at the site, so the anti-inflammatory and 
pain suppressing proteins in the saliva ensure the host is not irritated and thus the virus 
in the saliva enters the blood stream of a new host. The midgut and salivary gland of the 
mosquito, thus, are considered the two critical barrier sites (50). A single mosquito can 
infect multiple hosts in the process of blood feeding from each round of egg laying. 
Previous reports also indicate vertical transmission of various arboviruses including 
CHIKV occurs in the wild from mother to egg (54, 55). Vertical transmission in humans 
has also been reported but the period of gestation during infection has a significant effect 
on the viability of pregnancy and survival of progeny (51, 56). 
Considering the invasive nature of Ae. albopictus, it is considered only a matter of time 
before it establishes itself on the Australian mainland. Once a competent vector is 
established, autochthonous infections of CHIKV are inevitable. The current project aims 
to increase our understanding of the interaction between CHIKV and its new preferred 
vector Ae. albopictus at the two critical barrier sites through transcriptome studies. 
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1.5 Host-Pathogen Interactions 
With the objective of better understanding host-pathogen interactions, multiple studies 
have been published that report significant changes in transcriptional activity in the host 
during viral infections. Previous studies have used transcriptome-based approaches to 
identify mosquito-virus interactions, tissue-specific responses during the course of 
infection have not been characterised (57-62).  Here, using next-generation sequencing, 
we characterised the whole transcriptome response at the midgut (the first barrier site) 
and head and thorax (containing the salivary glands and viral dissemination sites), in Ae. 
albopictus in response to CHIKV infection.   
Briefly, we infected lab reared Ae. albopictus mosquitoes with CHIKV by oral challenge. 
Two days post-infection, the midguts and eight days post-infection, heads and thoraxes 
of the mosquitoes were collected. Total RNA was isolated and RNA-Seq was performed 
to detect differentially expressed genes. 
We also analysed the viral genome reads obtained from the midgut and head and thorax 
of the mosquitoes and compared the sequence to the original mammalian host origin viral 
sequence.  
The objective of this project is to gain a clearer understanding of the host-pathogen 
interactions between CHIKV and Ae. albopictus mosquito at the two critical barrier sites 
to a transcriptome level through an un-biased RNA-Seq approach. The study also helps 
in understanding the modifications the viral genome undergoes as it transfers from a 
mammalian host to a mosquito vector. 
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2.1 Abstract:  
Chikungunya virus (CHIKV) is an emerging pathogen around the world and causes 
significant morbidity in patients. A single amino acid mutation in the envelope protein 
of CHIKV has led to a shift in vector preference towards Aedes albopictus. While 
mosquitoes are known to mount an antiviral immune response post-infection, molecular 
interactions during the course of infection at the tissue level remain largely 
uncharacterised. We performed whole transcriptome analysis on dissected midguts of 
Aedes albopictus infected with CHIKV to identify differentially expressed genes. For this, 
RNA was extracted at two days post-infection (2-dpi) from pooled midguts. We initially 
identified 25 differentially expressed genes (p-value <0.05) when mapped to a reference 
transcriptome. Further, multiple differentially expressed genes were identified from a 
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custom de novo transcriptome, which was assembled using the reads that did not align 
with the reference genome. Thirteen of the identified transcripts, possibly involved in 
immunity, were validated by qRT-PCR. Homologues of seven of these genes were also 
found to be significantly upregulated in Aedes aegypti midguts 2 dpi, indicating a 
conserved mechanism at play. These results will help us to characterise the molecular 
interaction between Aedes albopictus and CHIKV and can be utilised to reduce the impact 
of this viral infection. 
Keywords: Chikungunya; Aedes albopictus; RNASeq; Host–pathogen interactions 
2.2 Introduction 
Arboviruses, such as the dengue, chikungunya, and Zika viruses, are a significant burden 
on public health systems worldwide. These viruses are transmitted by mosquitoes and 
can cause high morbidity and mortality, with dengue alone causing more than 300 
million infections per year [1]. First identified and described in 1955 in a report on an 
outbreak at the border of Tanzania and Mozambique in 1952, chikungunya virus 
(CHIKV) is an enveloped, positive sense RNA virus belonging to the alphavirus genus in 
the Togaviridae family [2,3]. CHIKV infection in humans causes high febrile illness, 
cutaneous exanthema and debilitating and often prolonged arthralgia [4–6].  
While Aedes aegypti is the traditional vector for CHIKV, Aedes albopictus has been observed 
to be implicated in viral transmission ever since the Reunion Island outbreak in 2005–
2006 [7]. A single amino acid change in codon 226 of the E1 gene, which encodes for the 
envelope protein of the virus, has improved the fitness of the Indian Ocean lineage 
CHIKV in Aedes albopictus [8]. As an invasive species, Aedes albopictus has been expanding 
its traditional habitat of tropical and sub-tropical regions to much cooler temperate 
regions. Aedes albopictus also survives in favourable microhabitats, even in winter and 
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freezing temperatures [9]. These factors have further increased the risk of CHIKV to cause 
outbreaks in areas where mosquito-borne viral diseases are uncommon, such as Northern 
America and temperate Europe [10,11]. 
For a mosquito to become infective, the virus needs to cross two critical barrier tissues: 
the midgut and salivary glands. These infection barriers can be influenced by multiple 
factors, including viral factors, such as viral glycoproteins, or vector factors, such as the 
presence of a viral receptor, host replication factors and the microbiome composition of 
the midgut [12]. When an adult female Aedes albopictus mosquito is exposed to CHIKV in 
the process of blood feeding, the virus infects the midgut usually in a matter of hours [13–
15]. Inside mosquitoes, after feeding, the blood meal moves down to the midgut where 
the virus must contact epithelial cells before digestion of the blood meal and formation 
of the peritrophic matrix takes place. Following the successful infection of the midgut, 
the virus must then overcome midgut escape barriers to disseminate to other tissues, such 
as the haemocoel [16]. From the haemocoel, the virus makes its way to the salivary glands 
of the mosquito. Once the virus is detected in the saliva, the mosquito is considered to be 
infective and a competent vector [17,18]. 
Since vector competence of the mosquito is initially dependent on infection of the midgut 
(Virus crossing the first critical barrier), understanding the molecular interactions 
between virus and mosquito midgut becomes essential. Although previous studies have 
used transcriptome-based approaches to identify mosquito–virus interactions, tissue-
specific responses during the course of infection are not well-understood [19–24]. Here, 
using next-generation sequencing, we characterised the whole transcriptome response at 
the midgut in Aedes albopictus in response to CHIKV infection. 
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2.3 Materials and Methods 
2.3.1 Chikungunya Virus 
Chikungunya virus isolate 06113879 (Mauritius strain), isolated from a viraemic traveller 
who returned to Australia in 2006, was obtained from the Victorian Infectious Diseases 
Reference Laboratory (VIDRL), Melbourne [25]. The isolate was passaged in Vero cells 
(ATCC, Virginia, USA) four times, followed by once in C6/36 (Aedes albopictus larval cell 
line) followed again by Vero cells, and was then used for the experiments. A TCID50 assay 
was performed on Vero cells to determine viral titer. 
2.3.2 Aedes Mosquito Rearing, Infection and RNA Extraction 
All experiments were performed under biosafety level 3 (BSL-3) conditions in the 
insectary at the Australian Animal Health Laboratory, CSIRO. Insectary conditions were 
maintained at 27.5 °C and 70% in relative humidity with a 12 h light and dark cycle. 
Female mosquitoes (5–8 days old) were challenged with a chicken blood meal spiked 
with CHIKV (1 in 100 dilution of stock virus, TCID50 1.5 × 109/mL) through chicken skin 
membrane feeding. After one hour, the mosquitoes were anesthetised with CO2, and the 
blood-fed females sorted and kept in 200 mL cardboard cup containers at 27.5 °C, 70% 
humidity and a 14:10 day:night photoperiod for 2 days with 10% sugar solution ad 
libitum. For controls, females were fed with blood mixed with media supernatant from 
an uninfected Vero cell culture. Midguts were dissected at 2 dpi and were stored in 50 µL 
of Qiagen RLTplus buffer with 5–10 silica beads (1 mm) at −80°C. 
Bead beating was performed on MP Biomedicals FastPrep -24™ homogeniser, 3 cycles, 
speed: 6.5 m/s, 45 s each cycle. RNA was extracted using the RNeasyTM kit (Qiagen 
Australia), and cDNA was generated by using random hexamers and Superscript-III 
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reverse transcriptase (Thermo Fisher Scientific Inc. Scoresby, Victoria, Australia) 
following the manufacturer’s protocols. 
Complementary DNA (cDNA) generated from the RNA extracted from the midguts 
pools was tested for CHIKV viral RNA using an in-house-designed qRT-PCR, using 
primers specific for the E1 gene (S1 Table). For RNASeq data validation, adult Aedes 
albopictus female mosquitoes were infected with CHIKV as described above. RNA was 
extracted from the midguts of 5 infected mosquitoes 2 dpi, and cDNA was generated 
individually by previously described protocols. cDNA from the midguts of 5 uninfected 
mosquitoes was used as controls. Mosquitoes from multiple generations but 
approximately of the same age were used for the experiments. 
For comparison of differential gene expression in Aedes aegypti, RNA was collected from 
the midguts of 6 mosquitoes and infected with CHIKV through blood feeding at 2 dpi. 
RNA that was extracted from the midguts of 5 uninfected mosquitoes was used as a 
control. cDNA was generated as described above and qPCR was performed with Aedes 
aegypti gene-specific primers. 
2.3.3 qPCR 
Quantitative PCR (qPCR) was performed using gene-specific primers and 18s rRNA 
specific primers as internal controls were used to validate the expression changes of 8 
targets. Midgut tissue from three infected and control mosquitoes was used for validation 
of 5 long non-coding RNAs (lncRNAs) by the above-mentioned method. 
qPCR was performed on an Applied Biosystems QuantStudio™ 6 using the SYBR Green 
Master Mix: SYBR Premix Ex Taq II (Tli RNase H Plus) (Takara- Scientifix Pty Ltd., 
Clayton, Victoria, Australia). The following cycling conditions were used with a melt 
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curve at the end, 30 s at 95 °C, 40 cycles of 5 s at 95 °C and 30 s at 60 °C. The baseline and 
Ct values were calculated automatically using the supplied QuantStudio™ Software 
(Thermo Fisher Scientific Inc. Scoresby, Victoria, Australia), and the ∆∆Ct values were 
calculated using the average ∆Ct value of controls and 18s rRNA as a reference. 
2.3.4 RNASeq and Viral Genome Sequencing 
To identify the genes involved in the initial infection stage, midguts from CHIKV-
infected Aedes albopictus mosquitoes at 2 dpi from 6 mosquitoes were pooled together for 
RNA extraction to obtain sufficient material. This was also required to avoid using a low-
RNA input RNAseq kit, which would likely introduce bias during the PCR amplification 
stage. The pool size was kept as low as possible to retain information on biological 
variations. 
Libraries for RNASeq were prepared using Nugen’s Ovation Universal RNASeq kit, 
following manufacturer’s specification with a minor modification in the HL-dsDNAse 
treatment. During first strand synthesis with DNase treatment, HL-dsDNase from 
Thermo Fisher Scientific was used in our library preparation, along with the 10x buffer 
supplied that their protocol used. The libraries were pooled and sequenced on a single 
lane of Hiseq-2500 (Macrogen Inc, Seoul, South Korea) to generate 2 × 100 bp reads. The 
fastq files were deposited in NCBI’s (National Center for Biotechnology Information) 
Sequence Read Archive (SRA Accession ID: SRP140387). 
The Qiagen QIAseq FX Single Cell RNA Library kit was used for Illumina library 
preparation from total RNA extracted from CHIKV-infected Vero cell culture 
supernatant using the RNeasyTM kit (Qiagen, Chadstone, Victoria, Australia). The library 
was sequenced on a Miniseq (Illumina, Scoresby, Victoria, Australia), with the mid-
output kit (300 cycles) generating 2 × 150 bp paired-end reads. The resultant fastq files 
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were quality-trimmed and assembled to a consensus sequence on the CLC Genomics 
workbench v9.5.2. The sequence was annotated and submitted to GenBank (MH229986). 
2.3.5 Differential Gene Expression and Gene Ontology Analysis 
Quality trimming of the raw sequences was performed using Trimmomatic v0.36. The 
reads were aligned to the CHIKV reference sequence (GenBank ID: MH229986) to assess 
the infection status using Hisat2 v2.0.5 [26]. 
Following removal of Gallus gallus (GenBank assembly accession: GCA_000002315.3) 
reads (due to chicken blood feeding) using SAMtools v1.3.1, the remaining reads were 
aligned to the Aedes albopictus Foshan strain genome sequence (AaloF1) from Vectorbase 
using Hisat2, and the resultant SAM file was sorted and converted into a BAM file using 
SAMtools [27,28]. 
On Galaxy virtual lab v1.4.6.p5, featureCounts v1.4.6-p5 was used to quantify aligned 
transcripts from the sorted BAM files with default parameters for paired-end reads, and 
DESeq2 v2.11.38 was used to obtain differentially expressed genes between the controls 
and infected samples by using default parameters [29,30]. 
Using Trinity v2.3.2, a custom de novo transcriptome was built by combining the 
unaligned reads from midguts (D2) [31,32]. This transcriptome was used as a reference 
genome. edgeR was used to align the reads, measure the transcript counts and quantify 
the differentially expressed genes. The differentially expressed genes were annotated 
using BlastX [33,34]. 
The gene ontology (GO) IDs of the differentially expressed genes were obtained using 
the Biomart tool, and topGO analysis was performed to identify the Molecular Functions 
(MF), Biological Processes (BP) and Cellular Components (CC) that were either enriched 
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or depleted in the differentially expressed genes [35,36]. Using topGO’s classic algorithm, 
and based on p-values generated using Fisher’s exact method, differentially expressed 
genes were grouped based on their ontologies. Enrichment percentage was calculated as 
the ratio of the number of times particular genes in the pathway were differentially 
expressed compared to the expected number by chance. 
2.4 Results 
2.4.1 Whole Genome Sequencing of CHIKV 
The chikungunya virus isolate 06113879 was used to infect Aedes albopictus mosquitoes. 
Although a 559 bp portion of the E1 gene has been published (GenBank ID: EU404186.1), 
full genome sequencing of this isolate has not been performed, which can inform us about 
the genotype of this virus as well as be used as a reference for removing the virus reads 
that are detected during the RNASeq analysis. 
Whole genome sequencing performed on the CHIKV isolate, after single Vero passaging, 
using the Illumina MiniSeq, resulted in about 8.5 million quality-trimmed, paired-end 
reads. The assembly resulted in an 11,929 bp long consensus sequence (MH229986), 
which perfectly matched the previously published 559 bp portion of the E1 gene from 
this isolate. 
The viral consensus sequence was most similar (Identity: 11,705/11,985 (97.7%), 
Similarity: 11,705/11,985 (97.7%), Gaps: 245/11,985 (2.0%)) to the CHIKV strain 
LR2006_OPY1 (GenBank: KT449801.1) and had the E1-A226V mutation, indicating that 
this isolate also belongs to the same lineage as the CHIKV that caused the La Reunion 
outbreak in the Indian ocean in 2006. 
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2.4.2 RNASeq 
To determine differentially expressed genes, five pools of midguts (six mosquitoes per 
pool) collected at 2 dpi from infected mosquitoes were created. For controls, three pools 
of midguts were used. Initially, to determine the infection status of these tissues, qRT-
PCR was performed using CHIKV-specific primers. Based on these results and 
qualitative and quantitative requirements of the Nugen Ovation universal RNAseq kit, 
two control and three infected midgut pools were used to prepare sequencing libraries. 
The sequencing of five libraries on a single lane of HiSeq-2500 resulted in 37 million to 
170 million reads each. After quality trimming, reads mapping to the chicken genome 
were discarded to remove those originating from undigested chicken blood. The 
remaining reads were aligned to the Aedes albopictus reference genome with an average 
alignment of 62.25%. The read alignment to the CHIKV reference sequence (MH229986) 
also confirmed that all the three infected libraries contained viral reads, while the two 
control libraries did not, as shown in Table 2.1. 
Table 2.1 RNASeq next-generation sequencing (NGS) data summary. 
 
Total Reads  
(millions) 
% Mapped to  
RefSeq Genome 
% of CHIKV Reads 
Infected MG 1 170.65 60.83% 0.01% 
Infected MG 2 37.13 60.46% 0.02% 
Infected MG 3 38.02 65.28% 0.10% 
Control MG1 44.77 61.53% 0.00% 
Control MG2 44.72 63.15% 0.00% 
The total number of obtained reads, the reads’ alignment percentage to the reference genome and the 
percentage of reads aligned to the chikungunya virus genome. 
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2.4.3 Differential Expression and TopGO Analysis 
Differentially expressed genes were identified using DESeq2 (for reads aligned to the 
RefSeq genome) and edgeR (for the de novo transcriptome built with aligned reads) and 
were plotted as Volcano plots (Figure 2.1). The results showed 25 genes to be 
differentially expressed as detected by DESeq2 (Up: 14 and Down: 11). edgeR did not 
show statistically significant (False Discovery Rate <0.05) differential expression of genes 
due to a sub-optimal number of control libraries. However, targets from this dataset were 
chosen based on raw p-values for validation. The complete list of genes and transcripts 
that were differentially expressed with p-values of less than 0.05 is provided in 
supplementary information S2. The fasta files that were obtained as output for the custom 
transcriptome assembly are provided in supplementary information S3. 
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Figure 2.1 Volcano plots from DESeq2 and edgeR for 2 dpi differential gene expression; Volcano plots 
from DESeq2 (top panel) and edgeR (bottom panel) of differentially expressed genes from 2 dpi. DESeq2 
was performed by aligning reads to the Aedes albopictus reference genome. edgeR analysis was done on 
reads that did not align to the reference genome and were aligned to the custom transcriptome. 
To determine the biological processes and molecular functions of the differentially 
expressed genes, gene set enrichment analysis and ontology was performed using topGO 
(Figure 2.2). As expected, several biological and molecular processes were significantly 
affected during CHIKV infection.
34 
 
 
Figure 2.2 topGo enrichment comparison in differentially expressed genes. Enrichment analysis of down- and upregulated genes in the midguts of 
Aedes albopictus mosquitoes in response to Chikungunya virus (CHIKV) at 2 dpi. Enrichment % is calculated as the ratio of ‘significant’ (Number 
of times the gene ontology number is observed as differentially expressed) to ‘expected’ (Number of times the gene ontology number is expected 
based on observation in control samples) gene numbers
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The differentially regulated biological processes were metabolic (p-value = 0.012) and the 
serine family amino acid biosynthetic process (p-value = 0.026). The differentially 
regulated molecular functions, likely of interest from an innate immune response point 
of view, were lysozyme activity (downregulated, p-value = 0.028), alkaline phosphatase 
(downregulated, p-value = 0.033) and carboxypeptidase activity (upregulated, p-value = 
0.042). 
Apart from protein-coding genes, five long non-coding RNA (lnc RNA) were also 
detected to be differentially expressed. These were >200 bp long sequences with no 
apparent reading frames and, when searched using Blast against the published Aedes 
albopictus genomes on NCBI, showed high similarity to sequences annotated as long non-
coding RNAs. 
2.4.4 RNASeq Data Validation on qRT-PCR 
Based on previously known immune involvement, we selected eight genes (one aligned 
to the reference genome and seven from the custom transcriptome) and five long non-
coding RNA (from the custom transcriptome) for validation by qRT-PCR (Table 2.2). For 
this, midguts were dissected from five individual CHIKV-infected adult Aedes albopictus 
female mosquitoes (2 dpi). Midguts from uninfected mosquitoes were used as controls.
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Table 2.2 List of genes validated by qRT-PCR and comparison of expression fold changes. 
Genes 
Aedes albopictus Aedes aegypti 
LogFC 
(RNAseq) 
Expression Fold 
Change (qRT-PCR) 
Expression Fold 
Change (qRT-PCR) 
ARF GTPase-activating protein GIT2 −8.7 0.76(↓) 39.74(↑) 
NPC2 homolog 6.29 5.35(↑) 11.63(↑)  
Mucin-22/FLO-11-like −8.61 0.16(↓) 7.34(↑) 
Translocon-associated protein subunit delta 8.82 1.88(↑) 40.18(↑) 
ATP-dependent RNA helicase dbp2 −9.07 6.53(↑) 26.22(↑) 
Uncharacterized gene coding for Sina and RING_Ubox 
domains containing protein 
8.84 1.51(↑) 41.07(↑) 
E3 ubiquitin-protein ligase MARCH6 −9.04 1.03(↑) 28.65(↑) 
Ankyrin repeat domain-containing protein 44 −5.56 0.5(↓) 
No homologue/Not 
tested 
PREDICTED: Aedes albopictus uncharacterized 
LOC109424229 (LOC109424229), ncRNA 
−11.22 2.14(↑) 
No homologue/Not 
tested 
PREDICTED: Aedes albopictus uncharacterized 
LOC109622934 (LOC109622934), ncRNA 
−7.13 0.06(↓) 
No homologue/Not 
tested 
PREDICTED: Aedes albopictus uncharacterized 
LOC109423409 (LOC109423409), ncRNA 
−9.07 0.73(↓) 
No homologue/Not 
tested 
PREDICTED: Aedes albopictus uncharacterized 
LOC109414360 (LOC109414360), ncRNA 
−9.53 1.02(↑) 
No homologue/Not 
tested 
PREDICTED: Aedes albopictus uncharacterized 
LOC109424229 (LOC109424229), ncRNA 
−8.98 0.04(↓) 
No homologue/Not 
tested 
 
As the results showed, for Aedes albopictus mosquitoes, among the eight protein coding 
transcripts chosen for validation, the expression pattern for six targets was concordant, 
and the expression pattern for two targets was discordant, between RNASeq and qRT-
PCR. Among the five tested long non-coding RNAs, two were concordant. All seven 
identified homologue targets, tested in Aedes aegypti midguts at 2 dpi, were upregulated 
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as compared to uninfected controls. In Aedes albopictus, only five of these targets were 
upregulated as per qRT-PCR. 
2.5 Discussion 
Chikungunya virus is a re-emerging alphavirus causing a high morbidity with long-term 
arthralgia in infected patients. Previous studies have taken approaches to understand the 
interaction between chikungunya virus and the Aedes aegypti vector, although these 
focused only on certain known genes and pathways [37]. However, considering the 
switch in vector preference towards Aedes albopictus by the Indian Ocean strains and 
invasive nature of this mosquito species, it is paramount to characterise the interaction 
between CHIKV and the new vector. 
Previous studies with whole transcriptome analysis in mosquito vectors have used either 
whole mosquitoes or a cell culture [19,21–23,38]. Our objective here was to study the 
vector–virus interaction specifically at the midgut, which is the first barrier site to 
understand the factors that play a critical role in determining mosquito vector 
competence. 
In the current study, unbiased transcriptional analysis was performed on midgut tissues 
collected from lab-reared adult female Aedes albopictus mosquitoes post CHIKV infection. 
The gene expression patterns, when compared to uninfected samples, revealed the 
transcriptional changes that are likely to be in response to the viral infection. Our analysis 
revealed that at 2 dpi in the midgut, most of the transcriptional changes were related to 
metabolism. An analysis of molecular functions revealed that while lysozyme activity 
and alkaline phosphatase were downregulated, carboxypeptidase activity was 
upregulated. Indeed, lysozymal and carboxypeptidase pathways have previously been 
implicated in innate immune responses [39–43]. 
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One of the genes that was identified to be upregulated, and later validated by qRT-PCR, 
was a homolog of the Neimann Pick 2 (NPC2) gene, which in humans encodes for an 
intracellular cholesterol transporter. Loss of function mutations in the NPC2 gene lead to 
a lysosomal disorder known as Niemann–Pick disease type C, which causes an increased 
accumulation of lipids in cellular compartments and leads to cell death [44,45]. In many 
viral infections, replication and assembly of the viral particles occur at the lysosomal and 
other intracellular membrane-bound organelles, including DENV infection in its vector 
Aedes aegypti [46]. NPC2 has previously been shown to be involved in the replication and 
transport of several viruses, such as ebolavirus, vesicular stomatitis virus and influenza 
A virus, into and out of cells [47–49]. Interestingly, we detected a significant upregulation 
of the NPC2 homolog both in Aedes albopictus as well as Aedes aegypti midguts 2 days post 
infection with CHIKV. Recent studies have shown that Imipramine-based inhibition of 
the NPC2 protein results in severely diminished CHIKV replication in human fibroblast 
skin cells [50]. The fact that the NPC2 gene is significant and essential for CHIKV 
replication in humans and is significantly upregulated in the mosquito midgut after 
infection implies that an evolutionarily conserved mechanism may be at play and 
presents possible therapeutic opportunities in clinical treatment. 
Multiple prior publications have also shown that the RNAi pathway is one of the major 
pathways involved in antiviral responses in insects [16,51–53]. We did not detect 
differential expression of the traditional innate-immune response pathways, such as 
JAK/STAT, IMD and Toll, consistent with previous studies with CHIKV infection of Aedes 
aegypti [37]. It is possible that the regulation of this pathway either does not occur at the 
transcriptional level or the proteins involved are ubiquitously expressed and not 
differentially regulated. It is also possible that the time point we selected did not coincide 
with RNAi activation. 
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Long non-coding RNAs are RNA molecules that are over 200 bp long and do not contain 
an open reading frame. They are produced by RNA Polymerase II and are processed like 
mRNAs by the cellular mechanism, including polyadenylation. lncRNAs have been 
implicated with involvement in multiple viral infections, including dengue and Influenza 
[39,54,55]. The mechanism of their involvement is complex, with pro or anti-viral activity 
[56–61]. Our understanding of lncRNA involvement in host viral interactions is still 
limited. Our results showed an increase in the number of lncRNAs in Aedes albopictus 
midguts after CHIKV challenge, suggesting a role during the infection. The functional 
significance of this differential regulation remains to be seen. 
While the DESeq2 analysis identified statistically significant differential gene expression, 
edgeR, performed on the custom transcriptome that was assembled using reads that did 
not align to the published Aedes albopictus reference genome, was not able to find 
significantly altered genes with the set FDR < 0.05. This may be due to the small sample 
size. 
To address this issue, we performed RT-qPCR-based validation of transcripts that 
appeared to be differentially expressed based on raw p-values, on a fresh set of individual 
mosquito midguts (five controls vs. five infected). RT-qPCR showed significant 
differential expression among all the transcripts tested, including in the targets from the 
edgeR dataset. These genes also showed differential expression when tested in CHIKV-
infected Aedes aegypti, further validating their significance during infection. 
The targets from the edgeR dataset, chosen for qPCR-based validation, were selected 
based on evidence from previously published data regarding their involvement in innate 
immune pathways. Seven out of eight protein coding targets and all of the five lncRNAs 
validated on RT-qPCR were from the edgeR dataset, and most showed varying levels of 
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differential expression. Functional characterisation of the identified genes may help us to 
decipher the results and understand their role in mosquito–virus interactions. 
Our results showed differences in gene expression pattern between Aedes aegypti and 
Aedes albopictus. While all of the seven tested genes in Aedes aegypti were upregulated, 
only five were upregulated in Aedes albopictus with the remaining two being 
downregulated. This may indicate differences in host–pathogen interactions between the 
two species of mosquitoes when infected with CHIKV. 
Overall, our results showed significant changes in the transcriptome of Aedes albopictus 
mosquitoes after CHIKV infection, with the identified genes being involved in multiple 
cellular processes. This study examined differential gene expression at the midgut (the 
first critical barrier site) in infected Aedes albopictus mosquitoes. This study can be utilised 
in determining potential pro-viral and antiviral host factors and, in turn, will be helpful 
in reducing the high impact of CHIKV infections by targeting the vector Aedes albopictus. 
Supplementary Materials: The following are available online at 
https://www.mdpi.com/1999-4915/11/6/513/s1, Table S1: List of primers, S2: List of 
differentially expressed genes, S3: Custom transcriptome output.  
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3.1 Abstract 
Chikungunya virus (CHIKV) is an alphavirus transmitted by Aedes mosquitoes and 
causes prolonged arthralgia in patients. After crossing the mosquito midgut barrier, virus 
disseminates to secondary tissues including the head and salivary glands. To better 
understand the interaction between Aedes albopictus and CHIKV, we performed RNASeq 
analysis on pools of mosquito head and thorax 8 days post-infection. The results 
identified 159 differentially expressed transcripts. After validation by RT-qPCR of 14 of 
the identified transcripts, Inhibitor of Bruton’s Tyrosine Kinase (BTKi), which has 
previously shown to be anti-inflammatory in mammals after viral infection, was further 
evaluated for its functional significance. Knockdown of BTKi using dsRNA in a mosquito 
cell line showed no significant difference in viral RNA or infectivity titer as measured by 
RT-qPCR or TCID50, respectively. However, BTKi gene knocked-down cells showed 
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increased apoptosis 24 hpi compared with control cells, suggesting involvement of BTKi 
in the mosquito response to viral infection. Since BTK in mammals promotes 
inflammatory response and has been shown to be involved in osteoclastogenesis, a 
hallmark of CHIKV pathogenesis, our results suggest a possible conserved mechanism at 
play between mosquitoes and mammals. Taken together, these results will add to our 
understanding of Aedes Albopictus interactions with CHIKV. 
Keywords: Chikungunya; Aedes albopictus; RNASeq; Host–pathogen interactions 
3.2 Introduction 
Chikungunya virus (CHIKV) is an enveloped, positive sense RNA virus belonging to the 
Alphavirus genus in Togaviridae family [1,2]. The virus causes a disease characterised by 
a high febrile illness and debilitating and protracted arthralgia [3-5]. 
Since the 2004-2005 outbreak in Reunion island, east of Africa, Aedes albopictus has played 
a significant role in expansion of CHIKV outbreaks around the world. A single mutation 
in the E1 viral gene has been shown to confer increased vector competence to this 
mosquito [6]. In the mosquito after blood-feeding, the virus needs to cross 2 critical 
barrier tissues, the midgut and salivary glands. The virus must infect and cross the 
epithelial cells before digestion of the blood meal and then overcome the midgut escape 
barriers to disseminate into the haemocoel, from where it reaches and infects other 
mosquito tissues including the salivary glands [7]. The mosquito is considered to be 
infective, once the virus is detected in the saliva [8,9].  
Previous research has identified a number of genes involved in early stages of Aedes 
albopictus infection with CHIKV [10]. However, to understand the interactions between 
the virus and mosquito at the transcriptomic level after dissemination of the virus, we 
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performed RNASeq analysis of the head and anterior 1/3rd part of mosquitoes (containing 
the salivary glands), collected 8 days post CHIKV infection. The results identified 
multiple differentially expressed genes, involved in various biological and molecular 
cellular functions. Our results identified BTKi to be functionally significant in the 
mosquito response to CHIKV infection. 
3.3 Results 
3.3.1 RNASeq and DGE analysis 
To determine differentially expressed genes, two pools of head/thorax (six per pool) 
collected at 8 dpi from infected mosquitoes were created. For controls, one pool of 
head/thorax from uninfected mosquitoes was used. The three libraries yielded between 
40.6 million and 47.15 million reads. After quality trimming and removing the reads 
mapping to the chicken genome, the remaining reads were aligned to the Aedes 
albopictus reference genome [Foshan strain genome sequence (AaloF1) from Vectorbase)]. 
The reads that did not map to the genome were then used to build a custom de novo 
transcriptome. The results confirmed the infection status of the two pools, and the control 
library contained no CHIKV reads as expected (Reference sequence: MH229986) (Table 
3.1). 
Table 3.1 RNASeq NGS data summary. 
 
Total reads 
(millions) 
% mapped to 
Refseq genome 
% of CHIKV reads 
Infected HT1 47.15 63.28% 1.12 
Infected HT2 40.60 60.35% 2.09 
Control HT 42.10 62.91% 0.00 
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Total reads obtained, their alignment percentage to the reference Aedes albopictus genome and the percentage of 
reads aligned to the chikungunya virus genome. 
Several differentially expressed genes were identified using both DESeq2 (for reads 
aligned to the RefSeq genome) and edgeR (for the de novo transcriptome built with 
unaligned reads) (Table 3.2) and the data is visualised as Volcano plots (Figure 3.1). The 
full list of genes and transcripts differentially expressed with p-values (and FDR) of less 
than 0.05 is provided in supplementary file S2 (Total: 159, Up: 74 & Down: 85). The fasta 
file obtained as output for the custom transcriptome assembly is provided in 
supplementary information S3. 
 
Figure  
Figure 3.1 Volcano plots from DESeq2 and edgeR 
Volcano plots from DESeq2 and edgeR of differentially expressed genes in CHIKV infected mosquito 
head/thorax compared to control. DESeq2 was performed by aligning reads to the reference Aedes 
albopictus genome; while edgeR analysis was done on reads that did not align to the reference genome 
and were aligned to the custom transcriptome. 
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Table 3.2 Differential Gene Expression analysis. 
No of Differentially expressed genes 
 Total Up Down 
DESe
q2 
96 51 45 
edgeR 63 23 40 
Number of genes found to be differentially expressed in mosquito head/thorax 8 dpi using DeSeq2 (p-
value: <0.05) and edgeR (FDR: <0.05) analysis. 
3.3.2 Ontology analysis 
Gene set enrichment analysis and ontology performed using TopGO revealed that 
several biological and molecular processes were significantly modified during CHIKV 
infection (Figure 3.2). The complete output of TopGO analysis is provided in 
supplementary data (S4).
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Figure 3.2 topGo enrichment comparison in differentially expressed genes 
Enrichment analysis of up and down regulated genes in the heads and thorax of Aedes albopictus mosquitoes in response to CHIKV at 8 dpi. 
Enrichment % is calculated as the ratio of ‘significant’ (Number of times the gene ontology number is observed as differentially expressed) to 
‘expected’ (Number of times the gene ontology number is expected based on observation in control samples) gene numbers.
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In the head/thorax of Aedes albopictus, upregulated molecular functions were RNA (p-
value: 0.046) and mRNA binding (p-value: 0.049) and molecular functions down regulated 
were lysozyme activity (p-value: 0.0038), serine-type endopeptidase activity (p-value: 
0.0058), protein heterodimerisation (p-value: 0.00181) and chitin binding (p-value: 0.00532). 
Biological processes down regulated were defence response (p-value: 9.70E-05), 
proteolysis (p-value: 0.0075) and chitin metabolic process (p-value: 0.0106). Up regulated 
biological processes were homophilic cell adhesion via plasma membrane (p-value: 
0.0056), UMP biosynthetic process (p-value: 0.0245), regulation of transport (p-value: 
0.0245), spliceosomal complex assembly (p-value: 0.0342).  
 
3.3.3 RT-qPCR based Validation of RNASeq data 
Fourteen differentially expressed genes were selected, based on previously described 
involvement in the immune response, for validation by RT-qPCR (11 aligned to reference 
genome and 3 from custom transcriptome) (see Table 3.3 for details). For this, head/thorax 
were dissected from five individual CHIKV-infected adult Aedes albopictus female 
mosquitoes (8 dpi). Head/thorax from uninfected mosquitoes were used as controls.
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Table 3.3 List of genes validated by qRT-PCR. 
  GeneID Gene Annotation 
1 AALF011899 Quaking protein A 
2 AALF004300 PREDICTED: PDZ and LIM domain protein 7-like isoform X1  
3 AALF008354 
Putative ecdysteroid-regulated 16 kDa protein 
[Source:UniProtKB/TrEMBL;Acc:A0A023EHE1] 
4 AALF012634 PREDICTED: fat-like cadherin-related tumor suppressor homolog [Aedes albopictus] 
5 AALF023547 Peptidylprolyl isomerase [Source:UniProtKB/TrEMBL;Acc:A0A023EQ01] 
6 AALF021910 PREDICTED: fasciclin-2-like isoform X1 [Aedes albopictus] 
7 AALF012324 glycine rich RNA binding protein, putative 
8 AALF016505 leucine-rich immune protein (Long) 
9 AALF025245 PREDICTED: inhibitor of Bruton tyrosine kinase [Aedes albopictus] 
10 AALF016704 
phosrestin i (arrestin b) (arrestin 2)  
[Source:Projected from Aedes aegypti (AAEL003116) VB Community Annotation]  
11 AALF026574 Putative uncharactarised protein containing CCHC zinc finger domain 
12 
TRINITY_DN12
9476_c0_g1_i1 
PREDICTED: protein no-on-transient A isoform X2 [Aedes albopictus] 
13 
TRINITY_DN13
1737_c0_g1_i2 
PREDICTED: ficolin-3-like [Aedes albopictus] 
14 
TRINITY_DN13
1885_c0_g2_i2 
PREDICTED: PDZ and LIM domain protein Zasp-like isoform X5 [Aedes albopictus] 
List of genes selected for validation by qRT-PCR and their annotation based on BlastX and BlastN.
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The qRT-PCR results, using gene-specific primers, compared with the RNAseq data 
(Table 3.4) showed that 7 out of 14 target genes were concordant. 
Table 3.4 Comparison of expression fold changes in chosen targets between qRT-PCR and RNASeq. 
Target ID Expression fold change (RT-qPCR) LogFC (RNASeq) 
AALF011899 0.8(↓) 2.54 
AALF004300 0.43(↓) 1.53 
AALF008354 0.96(↓) 2.07 
AALF012634 0.01(↓) 3.51 
AALF023547 0.75(↓) 2.24 
TRINITY_DN129476_c0_g1_i1 0.01(↓) -5.08 
TRINITY_DN131737_c0_g1_i2 0.07(↓) -6.42 
TRINITY_DN131885_c0_g2_i2 2.9(↑) 10 
AALF021910 2.97(↑) 3.55 
AALF012324 0(↓) 2.96 
AALF016505 3.65(↑) -1.65 
AALF025245 17.54(↑) 2.49 
AALF016704 1149.59(↑) 1.51 
AALF026574 0.09(↓) -3.12 
Results of RT-qPCR on the 14 gene targets selected from RNAseq DGE analysis. Expression fold change 
for RT-qPCR is calculated as 2^-ΔΔCt and the up or down regulation compared to controls is indicated 
by arrows, while LogFC (from RNA-Seq data) was calculated by DESeq2 and edgeR 
3.3.4 Functional significance of BTKi in CHIKV infected RML12 cells 
Inhibitor of Bruton’s tyrosine kinase (BTKi) was identified to be one of the significantly 
upregulated transcripts, both in RT-qPCR and RNASeq. To assess the functional 
significance of BTKi, Aedes albopictus larval cell line (RML12) was transfected with anti-
BTKi dsRNA. Twenty-four hours post transfection, the cells were infected with CHIKV 
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(MOI: 1). Twenty-four hours post infection, successful knockdown of BTKi was 
confirmed with RT-qPCR returning a ΔΔCt value of 2.39 (Expression fold change: 0.1913, 
Decrease in expression of BTKi: 80.87%). However, there were no significant changes in 
the viral RNA (ΔΔCt: -0.022, Expression fold change: 1.015) as well as TCID50 (Figure 3.3). 
Indicating, inhibition of BTKi, while detrimental to host cells, may not have a direct 
impact on viral replication. 
 
Figure 3.3 A: Comparison of BTKi expression between BTKi-KD and GFP-KD RML12 cells; B: 
Comparison of intracellular CHIKV RNA via RT-qPCR in BTKi and GFP knockdown RML12 cells; C: 
Comparison of % of apoptosis detected in BTKi-KD and GFP-KD RML12 cells; D: Comparison of TCID50 
of extracellular CHIKV between BTKi and GFP knockdown RML12 cells 
BTK has previously shown to be involved in inducing apoptosis. To determine whether 
similar pathways are involved in CHIKV-infected mosquito cells, anti-BTKi dsRNA 
transfected and CHIKV infected RML12 cells were grown on glass cover slips and 24 hpi 
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TUNEL staining was performed to quantify apoptosis. RML12 cells transfected with anti-
GFP dsRNA and infected with CHIKV were used as controls. Cell nuclei were stained 
using DAPI and apoptosis was measured as number of cells showing terminal 
deoxynucleotidyl transferase dUTP nick end labelling. Percentage of apoptosis was 
measured as ratio of apoptotic cells to DAPI stained cells (i.e. nuclei) (Figure 3.4). 
Significant apoptosis was detected in BTKi-KD cells compared to control cells (plot c), 
3.07% in BTKI-KD RML12 cells vs 0.186% in control RML12 cells (t: 2.0965, df: 16 & p: 
0.0261) (Figure 3.3).
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Figure 3.4 TUNEL staining of BTKi knocked down RML-12 cells post infection with CHIKV showing increased apoptosis compared to control 
RML12 cells (Scale bar: 50 µM).
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3.4 Discussion 
Multiple previous studies have been performed to understand the interactions between 
chikungunya virus and Aedes aegypti, the traditional vector [11-13]. Previously, RNASeq 
was performed on Aedes albopictus midguts 2 days post CHIKV infection which identified 
a number of differentially expressed genes[10]. These results helped in understanding 
the host-pathogen interaction at the first critical barrier site, the midgut. Yet, our 
understanding of transcriptome level interactions in Aedes albopictus, after viral 
dissemination is preliminary. We attempted to study the virus-vector interaction in the 
head/thorax region 8 dpi, as a proxy for dissemination site. This site is important as 
successful infection of salivary glands (included in the thorax) ensures the presence of 
virus in the saliva of the mosquito and in turn enables successful transmission. 
Our results show differential regulation of biological processes including RNA and 
mRNA binding, lysosomal and serpin pathways and down regulation of defensin genes. 
These could be due to either mosquito immune responses to CHIKV or viral modulation 
of immunity. Processes such as the regulation of transport and homophilic cell adhesion 
via plasma membrane could be involved in viral assembly and export [14-17]. Functional 
studies to determine whether these genes are pro or anti-viral are needed and could 
explain the role of these genes in the infection process.  
Interestingly, two odorant binding proteins (OBPs) were found to be differentially 
expressed. While Obp25 (AALF018602) was upregulated, D7 protein (AALF024478) was 
down regulated. In Aedes aegypti, salivary glands infected with dengue virus also showed 
differential expression of odorant binding proteins [18] and it was shown that down 
regulation of OBPs reduced the chemosensory abilities of the mosquitoes and hence 
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reduced exposure to virus via feeding and thus hindered transmission capabilities. Our 
results suggest that similar mechanisms may be in play here as well, although that 
remains to be verified with functional studies. 
The RNAi pathway is one of the major pathways involved in antiviral responses in insects 
[19-21]. Consistent with our previous study on Aedes albopictus midguts post CHIKV 
infection, our data does not show statistically significant changes in expression of genes 
involved in RNAi pathways in head and thorax. This is consistent with a previous study 
involving chikungunya virus and Aedes aegypti, where genes from JAK/STAT, IMD and 
Toll pathways were not found to be differentially regulated [11]. While it is possible that 
regulation of this pathway does not occur at the transcriptional level or RNAi proteins 
are not differentially regulated but ubiquitously expressed, more focused validation may 
provide a clearer conclusion to this observation. Expression levels at different time points 
post infections may also need to be assessed before reaching this conclusion. 
Our results showed that the concordance between our RNASeq and RT-qPCR data was 
low (50%). This was possibly because there were not enough biological replicates for 
RNA-Seq analysis. Higher concordance can be achieved by increasing the number of 
infected and control samples. For functional analysis, further research was focused on 
BTKi, which was validated through RT-qPCR. 
BTKi is an inhibitor of Bruton’s tyrosine kinase (Btk) [22]. Btk is heavily involved in 
innate-immune responses [23]. In higher level organisms, inactivating mutations in Btk 
results in a condition known as X-Linked agammaglobulinemia (XLA), characterised by 
inability to produce mature B-cells and gamma globulins (including antibodies). 
Increased susceptibility to apoptotic death on exposure to pathogen associated 
inflammatory signals is observed in BTK-deficient macrophages. BTK is involved in NK 
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cell activation via upregulated NF-κB pathway [24]. Btk along with Tec kinases are 
heavily involved in osteoclast differentiation and regulation. Severe osteopetrosis is 
observed in mice with non-functional Btk gene. Reduced osteoclastic bone resorption was 
observed in osteoporosis and inflammation-induced bone destruction on inhibition of 
Tec kinases. Btk and Tec kinases, among Tec Kinases are selectively expressed in 
osteoclasts and not in osteoblasts. Increased bone mass in mouse without Btk is due to 
defective osteoclastic bone resorption because of defective osteoclast differentiation [25]. 
CHIKV is known to infect osteoblasts and upregulate IL-6 and RANKL generation and 
decrease OPG production. An altered RANKL/OPG ratio gives rise to arthralgia, a 
characteristic morbidity of chikungunya fever [26]. Literature also presents evidence of 
benefit of Btk inhibition in viral inflammatory disease. Specifically, BTK inhibition with 
ibrutinib has shown major protective effect in lung tissue of mice during influenza viral 
infection by ameliorating excessive inflammatory response [27].  
Our data suggests that BTKi is significantly up-regulated in the head & thorax tissue of 
Aedes albopictus mosquito after chikungunya virus infection. While knock-down of BTKi 
in RML12 cells did not result in significant differences in viral titers or RNA levels, there 
was increased apoptosis in cells. These observations are consistent with a recently 
published study that show that inhibition of BTK is protective in host tissue during a viral 
infection [27]. In the context of CHIKV induced arthritis in patients, it is interesting to 
note that BTK is involved in osteoclastogenesis and inhibition of BTK on bone resorption 
is protective. Our data suggests a possible conserved mechanism at play for BTK and 
associated Tec kinases in the context of chikungunya infections in both mosquitoes and 
mammals. 
Overall, our results showed significant changes in the transcriptome of Aedes albopictus 
mosquitoes after CHIKV dissemination. This study, for the first time, examined 
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differential gene expression in the head and thorax (dissemination site containing 
salivary glands) of infected mosquitoes. Our results can be utilized in determining 
potential pro-viral and antiviral host factors and in turn, will be helpful in reducing the 
high impact of CHIKV infections by targeting the vector, Aedes albopictus. 
3.5 Materials and Methods  
Aedes albopictus mosquitoes were grown in BSL-3 insectary at the Australian Animal 
Health Labs with the following conditions, 27.5 °C and 70% in relative humidity with a 
12 h light and dark cycle. Five to eight-day old female mosquitoes were infected with 
CHIKV (1:100 dilution of stock, TCID50 1.5 × 109/mL) spiked in chicken blood, through 
membrane feeding for one hour. Post feeding, blood fed mosquitoes were separated and 
maintained in 200 mL cardboard containers at 27.5 °C, 70% humidity and a 14:10 
day:night photoperiod for 8 days with 10% sugar solution ad libitum. For controls, chicken 
blood mixed with media supernatant from uninfected Vero cell culture was fed to female 
mosquitoes. Eight days post infection, the heads and anterior 1/3rd of the thorax of the 
mosquitoes were dissected and tissue from 6 mosquitoes each were pooled into tubes, 
each with 50µL of Qiagen RLTplus buffer along with 5–10 silica beads (1 mm) and stored 
at −80 °C. 
Tissue homogenisation was performed on MP Biomedicals FastPrep -24™ homogeniser 
(3 cycles, speed: 6.5 m/s, 45s/cycle) via bead beating. RNA was then extracted using the 
RNeasy™ kit (Qiagen, Chadstone, Victoria, Australia). Complementary DNA was 
generated by using random hexamers and Superscript-III reverse transcriptase (Thermo 
Fisher Scientific Inc. Scoresby, Victoria, Australia) following the manufacturer’s 
protocols. cDNA generated from the RNA was tested for CHIKV RNA using an in-house-
designed qRT-PCR, using E1 gene specific primers (Table S1). For RNASeq data 
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validation, adult Aedes albopictus female mosquitoes were infected with CHIKV as 
described above. RNA was extracted from the HTs of 5 infected mosquitoes 8 dpi, and 
cDNA was generated individually by previously described protocols. cDNA from the 
head/thorax of 5 uninfected mosquitoes was used as controls.  
RNASeq libraries were prepared using Nugen’s Ovation Universal RNASeq kit, 
following manufacturer’s specification with a minor modification in the HL-dsDNAse 
treatment. HL-dsDNase from Thermo Fisher Scientific was used in our library 
preparation, along with the 10x buffer supplied that their protocol used. The libraries 
were pooled and sequenced on a single lane of Hiseq-2500 (Macrogen Inc., Seoul, South 
Korea) to generate 2 × 100 bp reads. The fastq files were deposited in NCBI’s (National 
Center for Biotechnology Information) Sequence Read Archive (SRA Accession ID: 
SRP140387). 
Gene-specific primers were designed for the 14 targets to be validated and using 18s 
rRNA as internal control, qPCR based validation was performed on an Applied 
Biosystems QuantStudio™ 6 using the SYBR Green Master Mix: SYBR Premix Ex Taq II 
(Tli RNase H Plus) (Takara- Scientifix Pty Ltd., Clayton, Victoria, Australia) (Cycling 
conditions: 30 s at 95 °C, 40 cycles of 5 s at 95 °C and 30 s at 60 °C and a melt curve). 
Thresh-hold cycle values were automatically calculated on the QuantStudio™ Software 
(Thermo Fisher Scientific Inc. Scoresby, Victoria, Australia). ∆∆Ct values were calculated 
using the average ∆Ct value of controls and 18s rRNA as a reference. All primer 
sequences are provided in supplementary table S1. 
Trimmomatic v0.36 was used for quality trimming of raw sequences [28]. Using Hisat2 
v2.0.5, the reads were aligned to CHIKV reference sequence (GenBank ID: MH229986) to 
assess infection status [29]. The reads were then aligned to the Aedes albopictus Foshan 
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strain genome sequence (AaloF1) from Vectorbase using Hisat2 [30]. The sorted Bam files 
were uploaded into Galaxy virtual lab v1.4.6.p5 and aligned transcripts were quantified 
using featureCounts [31]. Using default parameters, DESeq2 v2.11.38 was used to obtain 
differentially expressed genes [32]. 
A Custom de novo transcriptome was generated using Trinity v2.3.2, by combining the 
unaligned reads [33]. edgeR was used to align the reads, measure the transcript counts 
and quantify the differentially expressed genes using the custom transcriptome. Blastx 
and BlastN were used to annotate the genes [34,35]. 
Using topGO and based on p-values (Fisher’s exact method) differentially expressed 
genes were grouped based on their ontologies [36]. Enrichment percentage was 
calculated as the ratio of the number of times genes in the pathway were differentially 
expressed compared to the expected number by chance. 
Anti-BTKi dsRNA was generated by using a 422bp (Including the T7 promoter tag) long 
segment of the coding sequence as a template via the Invitrogen™ MEGAscript™ RNAi 
Kit by following manufacturer’s protocol (Reaction incubation time: 4 hours) (Primer 
details in supplementary table S1). RML12 cells were grown in modified Leibovitz's L-15 
Medium (For 400mL of L15 medium, 65mL of FCS, 40mL of TPB, 1.25mL of Pen-strep 
and 5mL of glutamine were added). Cells were maintained at 27°C with 1% CO2. 
RML12 cells, grown in 24 well plates, were transfected with anti-BTKI dsRNA using 
Cellfectin® II (Thermo Fisher Scientific, Australia) by following manufacturer’s protocol. 
Briefly, cells were incubated for 5 hours with a mixture of 800ng of purified dsRNA, 8µL 
of Cellfectin® II reagent and 240µL of transfection media (L15 medium with TPB and 
Glutamine but no FCS and antibiotics) per well. The mixture was replaced with normal 
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L15 growth medium at the end of incubation. For controls, RML12 cells were transfected 
with anti-GFP dsRNA. 
Twenty-four hours post transfection with dsRNA, the cells were infected with CHIKV 
(MOI: 1, Stock TCID50: 1.5x107/mL). Briefly, each well (in a 24 well plate) of RML12 cells 
were incubated for one hour with 250µl of infection medium (L15 medium with TPB and 
glutamine but no antibiotics and 2% FCS) and CHIKV. At the end of incubation, the 
infection media was replaced with regular L15 growth media.  
Twenty-four hours post infection, cell culture supernatant was collected and TCID50 
performed on Vero cells. RNA was extracted by lysing the monolayer of RML12 cells 
with 350µL of RLT Plus buffer. RNA extraction and cDNA generation were performed 
as described before. qPCR was performed to assess knock down of BTKI and change in 
viral RNA. 
For detection of apoptosis, RML12 cells were grown on glass cover slips (13mm diameter) 
compatible with 24 well plates. The cells were transfected with anti-BTKI dsRNA or anti-
GFP dsRNA (for controls) followed by CHIKV infection as described before. BD 
Cytofix/Cytoperm™ (BD Biosciences, Australia) was used to fix the cells for one hour and 
stored in PBS at 4°C. 
TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labelling) staining was 
performed using in situ cell death detection kit, TMR red (Sigma, Cat # 12156792910), as 
per manufacturer’s protocol and the nuclei was stained with 4′,6-Diamidine-2′-
phenylindole dihydrochloride (DAPI) (Sigma-aldrich). The cells were then imaged in 
Zeiss LSM 800 confocal system using 10x objective covering at least 500 cells per image. 
Percentage of TUNEL positive apoptotic cells against the total number of cells (DAPI 
stained nuclei) was quantified using ImageJ (particle analyser plugin) from each image.  
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Supplementary Materials: The following are available online at 
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4.1 Abstract  
Objective: Although RNA viruses have a very high mutation rate, arboviruses are 
constrained genetically due to fitness trade-off, when adapting simultaneously for 
infection and replication in mosquitoes as well as mammals.  Previous studies have 
identified genomic bottleneck events during mosquito infection, when virus crosses the 
midgut barrier before its replication in the body. Here, adult female Aedes albopictus 
mosquitoes were infected with chikungunya virus (CHIKV) by blood-feeding. RNASeq 
libraries prepared from pooled midguts (2 days post infection) and heads and the anterior 
1/3rd of the thorax (8 days post infection) were sequenced on an Illumina HiSeq-2500. 
Variant calling was performed on viral reads after alignment to a Vero cell-derived 
(input) consensus sequence (MH229986).  
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Results: Compared to mammalian Vero cell derived CHIKV sequence, there was a 
significant increase in the number of mutations in the viral genome in the midgut, 
followed by a substantial reduction in mutations in the viral genome from the head and 
thorax. These results indicate possible genomic bottleneck events during viral adaptation 
to the mosquito host system from a mammalian host system. 
Keywords: Chikungunya; Aedes albopictus; RNA-Seq; Host–pathogen interactions, 
Genomic diversity 
4.2 Introduction & Methods 
Traditionally transmitted by Aedes genus mosquitoes, chikungunya virus (CHIKV) has 
caused a massive outbreak starting 2005 and has now become endemic in tropical and 
Indian Ocean regions, infecting millions and causing high morbidity with long-term 
arthritis (1, 2). RNA viruses, such as CHIKV, have an inherent ability to rapidly mutate 
and generate variants for adaptation in novel environments through an error-prone 
polymerase. Viral diversification during mosquito infection is thought to be driven by 
the host immune system leading to evolution of new genotypes (3). Previous study has 
shown that West Nile virus exhibits stochastic reductions in genetic diversity, which was 
recovered during intra-tissue population expansions (4). Here, we studied the 
chikungunya viral genome as the virus infects and disseminates in the mosquito to reach 
the salivary glands from a mammalian host (Vero cells). 
Whole genomic sequencing of the chikungunya virus (Isolate 06113879), isolated from a 
viremic traveller who returned to Australia from Mauritius and passaged in Vero cells (4 
passages),once in C6/36 cells and once more in Vero cells was performed previously and 
the annotated consensus sequence deposited in GenBank (ID: MH229986) (5). Ae. 
albopictus mosquitoes were challenged with CHIKV (1 in 100 dilution of stock virus, 
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TCID50 1.5 × 109/mL). RNA-Seq libraries were prepared from RNA extracted at 2- and 8-
days post infection from Ae. albopictus midguts and heads and thoraces respectively. 
Sequencing was performed on a single lane of Illumina HiSeq-2500. Qality trimming of 
the sequence reads was performed using Trimmomatic. SAMtools was used to extract 
CHIKV reads, from the 2-dpi midgut and 8-dpi head/thorax RNA-Seq libraries. These 
reads were mapped to the reference sequence generated from the whole genome 
sequencing of the original Vero cell culture isolate of the virus. The RNA-Seq libraries 
contained varying number of reads. To account for this, reads were subsampled 
randomly to the library with lowest number of viral reads (4064 reads). Variant calling 
(SNPs and INDELs >5%) was performed using Varscan2 v2.3.9 on sub-sampled 
individual libraries as well as all midgut libraries merged together and all head/thorax 
libraries merged together (6, 7). 
The current data is a result of an extended analysis of our RNA-Seq data to assess 
transcriptional changes in Ae. albopictus midguts and head and thorax in response to 
CHIKV infection. Detailed methods are described in our previous publications (8, 9). 
4.3 Results & Discussion 
Earlier studies have shown that significant viral genetic bottleneck events occur during 
arbovirus infection in mosquito vectors (10, 11). Each bottleneck event may result in 
significant reduction in viral variant diversity and thus affects the viral variant ultimately 
transmitted via mosquito saliva to a susceptible mammal. To determine the CHIKV 
variant diversity in midgut and head/thorax samples, we used a previously sequenced 
CHIKV isolate 06113879 (5). Briefly, after passaging in Vero cells, whole genome 
sequencing was performed using the Illumina MiniSeq, resulting in about 8.5 million 
quality trimmed paired end reads. The assembly resulted in an 11,929bp long consensus 
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sequence, which perfectly matched a 559bp portion of the E1 gene from this isolate 
already in the database (GenBank ID: EU404186.1). 
Reads from the Vero isolate, as well as from midgut and head/thorax, were compared 
with the consensus sequence to determine the number of mutations in each sample 
(Figure 4.1). The number of mutations in the coding region of the midgut samples (50; 
SNPs: 43 and Indels: 7) were substantially higher compared with Vero (16; SNPs: 9 and 
Indels: 7), while the number of mutations in head/thorax were lower compared with other 
samples (7; SNPs: 4 and Indels: 3). The A226V variant in the E1 gene of the virus was 
identified and maintained from the mammalian host all the way to the viral reads 
extracted from the head and thorax of the mosquito indicating this virus’s fitness for Ae. 
albopictus mosquito (12) and its potential origin from the Indian Ocean region. Two 
variants appear in D8 samples that were not detected in either the midgut samples or the 
Vero cell samples. They may have existed in low level, below the limit of detection in the 
previous two samples and only appears when the other variants disappeared. They could 
also be novel variants that occurred in the viral genome during the replication in the 
mosquito tissue. A definitive conclusion cannot be drawn without additional work. 
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Figure 4.1 Total number of unique variants (coding and non-Coding) from CHIKV from Vero cells (Vero), 
Ae. albopictus midguts (D2) and head and thoraces (D8). Size of the circle is proportional to the number 
of variants as denoted.
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The location of the SNPs and Indels with respect to their location in the CHIKV genome are presented in Figure 4.2.  
Figure 4.2 Variants detected in Vero cell culture isolate, midgut and head/thorax independent libraries plotted as per their location on the CHIKV 
genome 
SNPs (red circles) and indels (blue circles) detected in the viral extract from Vero cell culture, three midgut pools and two head/thorax pools are 
plotted with reference to their position on the viral genome. The variants were called using Varscan2 and the figure was generated using R-Studio 
and annotated in Inkscape v0.91.
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Arbovirus evolution is constrained by the requirement for alternating replication in 
vertebrate host and mosquito vectors. Here we found mutations in both the midgut and 
head/thorax and possible genomic bottleneck events that might indicate adaptation of the 
virus to the mammalian and mosquito cellular environments. Vero cells (derived from 
African green monkey kidney), are known to be type-1 interferon response deficient (13). 
Without any antibody-type and interferon response, there may be limited incentive for 
viral genome adaptation. The low amount of CHIKV viral diversity from Vero cell culture 
isolate is also consistent with previous literature (14). While it is also possible that a sub-
population of CHIKV is selected resulting in low genomic divergence, more research is 
needed in this area. Our results suggest that this diversity increases significantly in the 
mosquito midgut samples at 2-dpi. We hypothesise that this increased genomic diversity 
represents CHIKV adapting and replicating in the mosquito midgut milieu. Interestingly, 
the number of CHIKV viral variants decreased considerably in head/thorax by 8-dpi, 
possibly indicating a genetic bottleneck and adaptation of virus after dissemination. 
These results are consistent with previous literature that show an increase in CHIKV 
fitness and its adaptability during host switch (15). The 3’-UTR of the CHIKV genome 
showed high variation in all our samples. This region enhances viral replication in 
mosquitoes by interacting with mosquito cell-specific factors (14). It contains highly 
conserved sequence elements for viral replication, binding sites for cellular miRNAs that 
determine cell tropism, host range, and pathogenesis, and conserved binding regions for 
a cellular protein that influences viral RNA stability (16).  Although significant, it is 
possible that this may be due to sequencing errors at this AT-rich region.  It is also 
interesting to note that the number of variants common between different tissue samples 
was very low, which is consistent with previous report (4). While the results are 
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consistent with previous literature (17), they are indicative of a bottleneck and our results 
add to existing knowledge in the subject of viral genomic diversity changes in mosquito 
vector during infection.   
List of abbreviations: CHIKV- Chikungunya virus, dpi- Days post infection, MG- 
Midgut, HT- Head & Thorax 
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5.1 Abstract 
Chikungunya virus (CHIKV) is an alphavirus belonging to Togaviridae family. Following 
a single nucleotide mutation in the E1 gene of the virus, Aedes albopictus has improved 
vector competence for CHIKV. Previously we performed RNASeq analysis of Aedes 
albopictus midguts, 2 days post infection with CHIKV. Differential gene expression 
analysis showed an upregulation of Niemann-Pick 2 (NPC2) gene homologue (LogFC: 
6.29), which was confirmed via RT-qPCR in independent samples (Expression fold 
change: 5.35). Our results also showed that NPC2 gene is also upregulated significantly 
(Expression fold change: 11.63) in Aedes aegypti mosquitoes infected with CHIKV. NPC2 
gene, which encodes for an intracellular cholesterol transporter protein was previously 
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shown to be essential for CHIKV replication in human fibroblasts and when inhibited, 
severely diminished viral replication. To verify the functional significance in mosquito 
infection, we overexpressed NPC2 gene in an Ae. albopictus cell line followed by infection 
with CHIKV. Twenty-four hours post-infection, while there were no significant 
differences in extracellular (as measured by TCID50) and intracellular CHIKV (as 
measured by ∆Ct), confocal imaging showed partial co-localisation NPC2 protein (V5 tag) 
and virus particles (pan-Alphavirus antibody) around membrane bound organelles. Our 
results indicate that while NPC2 may be implicated in CHIKV infection of Ae. albopictus 
mosquitoes, its actual role during infection remains to be characterized.  
5.2 Introduction 
Chikungunya virus is a re-emerging arbovirus from the Alphavirus genus in Togaviridae 
family. Single nucleotide change in the E1 gene of the virus has led to its increased vector 
competence in the Aedes albopictus mosquitoes (1). This change in the virus sequence has 
caused the last major outbreak since around 2005 in the East African Reunion island and 
has since spread to majority of the land mass in the Indian ocean region where seasonal 
outbreaks are now normal (2). The traditional vector for CHIKV is Ae. aegypti, a mosquito 
well adapted to living in close proximity to human settlements in tropical regions with 
well understood dawn-dusk feeding cycle (3). The new vector, Ae. albopictus, is an 
invasive pest with greater tolerance to cold and temperate weather zones and aggressive 
feeding patterns (4). These attributes have conferred advantages to CHIKV and 
chikungunya fever outbreaks have been noted in regions where arboviral disease 
outbreaks are uncommon, including temperate Europe (Italy) and northern United states 
(5, 6).  CHIKV causes a severe febrile illness with prolonged arthralgia (7, 8). Treatment 
is symptomatic and no proven vaccine exists (9). While rate of mortality is low, the 
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economic impact on a region due to hospitalisations of patients and loss of productive 
man hours is significant (10, 11).  
In our previous publication, we showed that a Neiman Pick-2 (NPC2) gene homologue is 
significantly upregulated in the midguts of both Ae. albopictus and Ae. aegypti mosquitoes, 
2 days post-infection with CHIKV (12). Literature suggested NPC2 protein to be essential 
for successful replication of CHIKV in human fibroblast cells (13). To further understand 
the functional significance of NPC2 gene during CHIKV infection in Ae. albopictus, we 
overexpressed the gene by transfecting C6/36 cells with a plasmid containing the NPC2 
coding sequence before CHIKV infection. The results showed that overexpression did not 
have an impact on CHIKV titers. 
5.3 Materials and Methods 
Chikungunya virus isolate 06113879, originally isolated from a viremic traveller from 
Mauritius was obtained from the Victorian Infectious Diseases Reference Laboratory 
(VIDRL), Melbourne. The virus isolate also contained the E246V mutation and was most 
similar to the Indian Ocean region isolate that had also caused the Reunion island 
outbreak. All experiments were performed under biosafety level 3 (BSL-3) conditions at 
the Australian Animal Health Laboratory, CSIRO.  
The coding sequence of NPC2 gene homologue was amplified from cDNA, prepared 
from complete RNA extracted from a CHIKV infected Aedes albopictus, using the gene 
specific primers (details provided in the supplementary data) and cloned into the 
pIZ/V5-His (Thermo Scientific) plasmid after restriction digestion with HindIII & XbaI 
(NEB) and ligation with T4 ligation enzyme (NEB). Electrocompetent DH5α Escherichia 
Coli were transformed with PiZ plasmid with NPC2 insert using a Bio-Rad Gene Pulser 
Xcell™ Electroporation Systems and grown on Zeocin infused (35µl per 100ml) low salt 
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LB agar plates. Successful integration of the sequence in the cloning site in-frame with 
the V5 tag was confirmed via Sanger sequencing post extraction of plasmid using Qiagen 
MiniPrep kit. The bacterial plug containing the clone with right insert was grown 
overnight in 500ml of low salt LB broth with Zeocin (35µl per 100ml) with shaking and 
the cloned plasmid extracted using the Qiagen MidiPrep kit to obtain endotoxin free 
plasmid. All procedures were followed as per the respective manufacturer’s 
recommendations without modifications. 
C6/36 cells, which are a continues cell line derived from Ae. albopictus larvae (14),  were 
grown in Leibovitz's L-15 Medium (For 400 ml of L15 medium, 65ml of FCS, 40ml of TPB, 
1.25ml of Pen-strep and 5ml of Glutamine were added) and maintained at 27°C. 
Transfection of cells were performed using FlyFectin™ Transfection Reagent (OZ 
Biosciences, San Diego, CA) at 1.5µg plasmid DNA to 6µL reagent per well of 70% 
confluent cells, mixed with 250µl of transfection L15 medium (L15 medium with TPB and 
Glutamine but no FCS and antibiotics) incubated for 5 hours. After five hours of 
incubation, the mixture was replaced with L15 growth medium. For controls, C6/36 cells 
were transfected with GFP expressing pIZ plasmid. 
Twenty-four hours post-transfection, the cells were infected with CHIKV (MOI: 1). 
Briefly, the growth medium on the cells grown in 24-well plates, was replaced with 250µl 
of infection medium (L15 medium with TPB and Glutamine but no antibiotics and 2% 
FCS) and CHIKV per well. The cells were incubated for one hour after which the infection 
medium was replaced with regular L15 growth medium.  
Twenty-four hours post-infection, the supernatant from three wells was collected for 
TCID50. The cell monolayer was lysed using 350µl of RLT+ buffer. RNA was extracted 
from the same three wells and cDNA prepared using methods previously described (12). 
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Quantitative PCR (qPCR) was performed on technical triplicates using NPC2 and CHIKV 
sequence specific primers. 18s rRNA specific primers were used as internal controls to 
calculate ΔCt values. qPCR was performed on an Applied Biosystems QuantStudio™ 6 
using the Takara-Clontech SYBR Green Master Mix: SYBR Premix Ex Taq II (Tli RNase H 
Plus). The following cycling conditions were used with a melt curve analysis at the end. 
Cycling conditions were: 30 seconds at 95°C, 40 cycles of 5 seconds at 95°C and 30 seconds 
at 60°C followed by a melt curve. The baseline and Ct values were calculated 
automatically using the supplied QuantStudio™ Software. 
TCID50 assay was performed on Vero cells, using the supernatant from the three NPC2-
pIZ or GFP-pIZ transfected C6/36 cells. Wells of cells showing cytopathic effects were 
counted 4 days post infection and infectivity titer measurements were calculated using 
the Spearman & Kärber algorithm (15).  
For Confocal microscopy, C6/36 cells were grown on glass cover slips (13mm diameter) 
compatible with 24-well plates as described before in chapter 3. The cells were transfected 
using NPC2-pIZ and GFP-pIZ plasmids (1.5µg/well). Twenty-four hours post-
transfection, they were infected with CHIKV (MOI: 1). The cells were then fixed using 
BD Cytofix/Cytoperm™ (BD Biosciences, Australia) for one hour and stored in PBS at 
4°C. The cells were stained with an Anti-V5 tag antibody (ab9116, 1:100) (abcam, USA) 
and an alphavirus antibody (3581, sc-58088, 1:50) (Santa Cruz Biotechnology, Dallas, 
Texas, U.S.A) and 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI) (Sigma-
Aldrich). Briefly, cells were permeabilized in 0.1% Triton X-100 in PBS for 5 mins, blocked 
for 30 mins with 0.5% BSA in PBS and incubated with primary antibodies for 16 h at 4 °C. 
AlexaFluor-594 or 647 conjugated anti-mouse or anti-Rabbit secondary antibodies (1:200; 
ThermoFisher Scientific) were incubated for 1 h at room temperature, cells were then 
stained with DAPI and mounted on slides using Vectashield mounting medium (Vector 
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Laboratories). The cells were imaged on Zeiss LSM 800 confocal microscope and image 
analysis was performed on Zen lite software (v2.6). 
5.4 Results 
Initial experiments were performed to check whether overexpression of mosquito NPC2 
homologue has any effect on CHIKV titers in mosquito cells. C6/36 cells were transfected 
with plasmid containing Ae. albopictus NPC2 gene homologue. As a control, cells were 
transfected with GFP plasmid. Cells were infected with CHIKV 24 hours post-
trasnfection and samples were collected 24 hpi. While there was successful over 
expression of NPC2 gene homologue (Expression fold change: 1473.012) as measured by 
realtime RT-qPCR, there was no significant difference in intracellular CHIKV RNA 
between NPC2 and GFP overexpressing C6/36 cells (Expression fold change: 1.04) (Figure 
5.1a). TCID50 was performed on cell culture supernatant from the two conditions 24 hpi 
and the results did not show significant difference (Figure 5.1b).  
 
Figure 5.1 Comparison of fold change NPC2 and CHIKV & CHIKV TCID50 between GFP/NPC2 
overexpressing C6/36 cells 
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In mammals, NPC2 has previously been identified as an intracellular cholesterol 
transporter, involved in egress of cholesterol from the late endosomal/ lysosomal 
compartment (16). NPC2 has been implicated in CHIKV replication in human fibroblasts. 
To determine whether NPC2 co-localises with CHIKV in mosquito cells, confocal 
microscopy was performed on C6/36 cells overexpressing NPC2 and infected with 
CHIKV. Cells that showed both NPC2 over expression (visualised through staining with 
anti-V5 antibody) and CHIKV infection (Visualised through staining with pan-
alphavirus antibody) were manually scanned for localisation patterns. Confocal imaging 
showed vesicular and membrane bound localization of overexpressed NPC2 protein. 
Viral particles partially co-localised with NPC2 at the cell membranes (Fig 5.2a) or 
vesicles (Fig 5.2b). Cells that showed the two patterns, i.e. cytoplasmic and vesicular 
localisations were imaged. Up to 10-20 Airyscan images of the selected cells were taken 
in total. No special treatment was applied to visualise the vesicular localisation. 
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Figure 5.2C6/36 cells over expressing NPC2 protein, infected with CHIKV.  
NPC2 protein (Green) is localised to membranes (a) and vesicles (b) and confocal imaging shows partial co-localisation of CHIKV (Red) particles 
to the same areas. Nucleus is stained with DAPI (Blue) (Scale bar: 50 µM).
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5.5 Discussion 
Our previous study identified NPC2 homologue to be significantly upregulated in the 
midguts of Ae. aegypti and Ae. albopictus after CHIKV infection (12). Primarily existing in 
lysosomes and late endosomes, NPC2 is a small soluble lipid transporter that mediates 
movement of cholesterol molecules in conjunction with NPC1 in cells (17). In humans, 
NPC2 gene is located on the X-chromosome and loss of function mutations causes 
pathological accumulation of lipid particles in cells causing a condition called Niemann-
Pick disease. Characterised by build-up of cholesterol within cells, the condition 
manifests into several impairments including but not limited to neurological, lung and 
liver problems. Abnormal accumulation of lipids in cells eventually result in cell death 
and tissue injury (17-19). 
NPC family proteins were shown to be involved in multiple viral replication and cell 
entry-exit mechanisms including ebolavirus (20-23) and HIV1 (24). Apart from these, 
multiple viruses including Influenza A (25) and vesicular stomatitis virus (26) use lipid 
membrane rafts which are also associated with NPC family proteins.   
Interestingly, CHIKV replication is completely restricted when NPC proteins were 
inhibited using Imipramine in human fibroblast cells. Flaviviruses including dengue and 
Zika viruses also exhibited diminished replication on inhibition of NPC proteins using 
Imipramine (13). The fact that the same family of proteins are involved in viral infections 
in multiple vectors (evident from upregulation in both Ae. aegypti and Ae. albopictus 
midguts) and higher order animals including humans indicates their highly conserved 
involvement.  
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Our results showed that there was no significant change in the infectivity titers and viral 
RNA quantities in cells that over-expressed NPC2, possibly indicating the relationship is 
not rate-limiting in nature, i.e. more NPC2 protein may not lead to more virus replication 
or production. Although, we were not able to establish direct implications of NPC2 
during CHIKV infection, more research needs to be performed to confirm this. Previous 
research has also indicated that the E1-226 mutant CHIKV strain may not be cholesterol 
dependent (27), which may be relevant in this research. However, on confocal imaging, 
we could see viral clustering around membranes and vesicles stained by NPC2 proteins. 
This observation is consistent with previous literature that suggest NPC protein 
involvement in lipid transport and multiple viruses depending on the lipid transport 
mechanisms for entry/exit into cells and movement of different viral particles inside cells 
between endosomal and lysosomal systems, indicating the significance of NPC proteins 
in viral infections (13, 21, 22, 24). Our findings indicate that although NPC2 did not play 
a role in mosquito viral replication at the conditions tested, its exact role remains to be 
identified. 
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Chapter 6: Discussion 
CHIKV is a re-emerging alphavirus causing a high morbidity with long term arthralgia. 
Previous studies have taken approaches to understand the interaction between CHIKV 
and the Ae. aegypti vector (1).  However, considering the switch in vector preference 
towards Ae. albopictus by Indian Ocean isolates (due to a single amino acid change) and 
invasive nature of this mosquito species, it is paramount to characterize the interaction 
between CHIKV and the new vector.  
One study has explored the interaction between CHIKV and Ae. Aegypti in the mosquito 
midgut (2). Previous studies with whole transcriptome analysis in mosquito vectors have 
used either whole mosquitoes or cell culture (3-7). Our objective here was to study the 
vector-virus interaction specifically at midgut, the first barrier site, and head/thorax, the 
second barrier site, which denote the dissemination sites and include salivary glands, to 
understand the factors that play a critical role in determining mosquito vector 
competence. 
Here we performed an unbiased transcriptional analysis on tissues collected from lab 
reared adult female Ae. albopictus mosquitoes at two different time points after exposure 
to CHIKV infection. The gene expression patterns at these tissue sites compared to 
uninfected samples revealed the transcriptional changes that are likely to be in response 
to the viral infection.  
The analysis revealed that 25 transcripts were differentially regulated at 2 dpi in midgut, 
with most of the transcriptional changes related to metabolism. Analysis of molecular 
functions revealed that while lysozyme activity and alkaline phosphatase were down 
regulated, carboxypeptidase activity was upregulated. Indeed, lysozymal and 
100 
 
carboxypeptidase pathways have previously been implicated in innate immune 
responses against multiple arboviral infections (8-11).  
At 8dpi in head/thorax, differential expression of 159 transcripts and differential 
regulation of biological processes including RNA and mRNA binding, lysosomal and 
serpin pathways and down regulation of defensin genes were observed. These could be 
due to either mosquito immune responses to CHIKV or viral modulation of immunity. 
Processes such as the regulation of transport and homophilic cell adhesion via plasma 
membrane could be involved in viral assembly and export (12-15). Functional studies to 
determine whether these genes are pro or anti-viral are needed and could explain the role 
of these genes in the infection process.  
Multiple prior publications have also shown that the RNAi pathway is one of the major 
pathways involved in anti-viral responses in insects (16-18). In this study, we did not find 
any statistically significant changes in expression of genes involved in the RNAi 
pathways. It is possible that the regulation of this pathway either does not occur at the 
transcriptional level or the proteins involved are ubiquitously expressed and not 
differentially regulated. It is also possible that the time points we selected did not coincide 
with RNAi activation.  
Twenty-two protein coding targets (8 from midguts/2dpi dataset and 14 from 
Head&Thorax/8dpi dataset) and 5 lncRNAs (all from midguts/2dpi dataset) were 
selected for validation by qRT-PCR, based on their possible involvement in mosquito 
immunity. The concordance was lower in the 8dpi genes compared to 2 dpi genes. This 
could be due to the lower number of replicates in 8 dpi samples in the RNA-Seq analysis. 
Seven targets from midguts/2dpi dataset were chosen for assessment of their differential 
expression status post infection with CHIKV in Ae. aegypti, the tradition vector. While the 
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seven chosen targets were differentially expressed in Ae. albopictus midguts 2dpi with 
CHIKV with varied regulation, all the seven targets tested were significantly upregulated 
in Ae. aegypti midguts. These results may indicate that although both Ae. albopictus and 
Ae. aegypti are from the same Aedes genus, there are significant differences between them 
when it comes to transcriptomic changes post CHIKV infection. This also indicates that 
the response of the mosquitoes to the virus could also be significantly different and may 
account for different vector competence, enough to warrant further study. 
List of all the primers used for this project are presented in Appendix-I. Appendix-II to V 
list the differentially expressed genes from edgeR and DESeq2 from midguts and head 
and thorax of Ae. albopictus, 2dpi and 8dpi with CHIKV. 
The incomplete and poorly annotated reference genome of Ae. albopictus was a hindrance 
in performing data analysis and robust pathway analysis. We also used heads and 
anterior 1/3rd of the thorax, which included salivary glands at 8 dpi. The results from these 
samples represent data from heterogeneous tissue, and care needs to be taken before any 
broad conclusions are drawn. Functional characterisation of the identified genes may 
help in deciphering the results and understanding their role in mosquito-virus 
interactions. 
RNA viruses, such as CHIKV, have an inherent ability to rapidly mutate and generate 
variants for adaptation in novel environments through an error-prone polymerase (19). 
Viral diversification is thought to be driven by the mosquito immune system leading to 
evolution of new genotypes (20). A study has shown that West Nile virus exhibits 
stochastic reductions in genetic diversity, which was recovered during intra-tissue 
population expansions (21). Here, utilising the high-throughput viral sequencing data, 
we showed that the mutations that arose in midgut and head/thorax samples compared 
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to the original Vero cell culture isolate indicate possible changes in the viral sequence as 
it adapts from a mammalian host to different mosquito tissues. Vero cells, derived from 
African green monkey kidney, are known to be type-1 interferon response deficient (22), 
which may result in a high amount of CHIKV viral diversity as seen by high number of 
viral variants. Our results suggest that this diversity increases significantly in the 
mosquito midgut samples at 2dpi. We hypothesise that this increased genomic diversity 
represents CHIKV adapting and replicating in the mosquito midgut milieu. Interestingly, 
the number of CHIKV viral variants decreased considerably in head/thorax by 8 dpi, 
possibly indicating a genetic bottleneck at this stage. These results are consistent with 
previous literature that show increase in CHIKV fitness and its adaptability during host 
switch (23). Additional research focussed on this observation may provide conclusive 
answers as to the nature of the changes observed in the viral genome. The CHIKV 3′-UTR 
enhances viral replication in mosquitoes by interacting with mosquito cell-specific 
factors. This region contains highly conserved sequence elements for viral replication, 
binding sites for cellular miRNAs that determine cell tropism, host range, and 
pathogenesis, and conserved binding regions for a cellular protein that influences viral 
RNA stability (24). The 3’-UTR of the CHIKV genome showed the most variation in all 
our samples. Although significant, this may also be due sequencing errors at this AT-rich 
region.  
A Neiman Pick-2 (NPC2) homologue transcript was found to be significantly upregulated 
in the midgut of Ae. albopictus mosquito 2 dpi with CHIKV both by RNA-Seq and RT-
qPCR. The same gene was also upregulated in the midgut of Ae. aegypti mosquito 2 dpi 
with CHIKV (25). Known to be a lipid transporter that localises to lysosomes and late 
endosomes, NPC family of proteins have previously been implicated in multiple viral 
infections and intra-cellular viral replication. NPC1 has been shown to be essential for 
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Ebola virus entry into cells, replication and pathogenesis (26, 27). In Ae. aegypti, NPC 
family members were shown to be agonists of dengue viral infection (28). NPC1 
deficiency is shown to impair the release of mature HIV1 particles (29). Most importantly, 
inhibition of NPC proteins by using Imipramine has been shown to successfully block 
replication of chikungunya virus in a rate limiting manner. This mechanism was also 
shown to be effective in blocking replication of flaviviruses including dengue and Zika 
viruses (30). Considering the significance of NPC proteins in viral infections, we 
attempted to assess the functional significance of the NPC2 upregulation in our dataset. 
NPC2 was over expressed in Ae. albopictus cell line, C6/36. Supernatant and RNA was 
collected from C6/36 cells, over-expressing NPC2 protein, 24 hours post infection with 
CHIKV. Compared to controls, C6/36 cells transfected with NPC2 expressing pIZ 
plasmid had significantly higher levels of NPC2 expression. However, there was no 
significant differences in extra-cellular infective mature viral particles as measured 
TCID50. Significant difference was also not detected in intra-cellular viral RNA levels as 
measured by RT-qPCR. On confocal microscopy, C6/36 being a mixed cell line, there were 
at least two different patterns of NPC2 distribution across the cells.  In one pattern, NPC2 
was localised to various intra-cellular membranes while in the second pattern, NPC2 
formed cytoplasmic vesicles. In both patterns, CHIKV and NPC2 are observed to be co-
localising. This observation is consistent with previous publications (referenced above) 
in that NPC2 proteins play a part in viral entry/exit of cells and participate in replication 
of viruses. While NPC2 over expression did not result in changes to quantity of viral 
particle or RNA, co-localisation of CHIKV particles and NPC2 protein suggest functional 
significance of NPC2 during viral pathogenesis in insect cells. 
A transcript that was significantly upregulated at 8 dpi in head/thorax, was Inhibitor of 
Bruton’s tyrosine kinase (BTKi). Bruton’s tyrosine kinase (BTK) is a non-receptor, cytosolic, 
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Tec kinase. BTK has been linked to multiple innate and adaptive immune system 
functions. In mammals, loss of function mutations in BTK gene is pathogenic and results 
in X-Linked agammaglobulinemia (XLA), a condition characterised by inability to 
produce mature B-cells and gamma globulins (including antibodies) (31). BTK-deficient 
macrophages show increased susceptibility to apoptosis when exposed to pathogen 
associated inflammatory signals. BTK is known to upregulate the NF-κB pathway and 
lead to NK cell activation (32).  
A classical symptom of CHIKV pathogenesis is severe arthralgia where patients 
experience prolonged muscle and joint pains (33). CHIKV is known to infect osteoblasts, 
the bone forming cells and upregulate Interleukin-6 (IL-6) and Receptor activator of 
nuclear factor kappa-Β ligand (RANKL) generation and decrease Osteoprotegerin (OPG) 
production. An altered RANKL/OPG ratio gives rise to arthralgia, a characteristic 
morbidity of chikungunya fever (34). 
Btk along with other Tec family kinases are heavily involved in osteoclast, the cells 
involved in bone resorption, differentiation and regulation. Severe osteopetrosis is 
observed in mice with non-functional Btk gene. Reduced osteoclastic bone resorption was 
observed in osteoporosis and inflammation-induced bone destruction on inhibition of 
Tec kinases. Btk and Tec kinases, among Tec Kinases are selectively expressed in 
osteoclasts and not in osteoblasts. Increased bone mass in mouse without Btk is due to 
defective osteoclastic bone resorption because of defective osteoclast differentiation (35). 
Literature also presents evidence of benefit of Btk inhibition in viral inflammatory 
disease. Specifically, BTK inhibition with ibrutinib has shown major protective effect in 
lung tissue of mice during influenza viral infection by ameliorating excessive 
inflammatory response (36). 
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Taking all published literature into account, inhibition of BTK appears to be protective to 
host cells as a method of limiting tissue damage due to inflammatory response. 
Particularly during CHIKV infection, inhibition of BTK may result in reduced bone loss. 
It is interesting to observe the significant upregulation of BTKi in the Aedes albopictus at a 
later stage of CHIKV infection in the site of dissemination. While definitive conclusions 
can not be drawn as to possible role of BTK or BTKi in humans and the effect of BTK 
inhibition during CHIKV, evidence to a highly conserved mechanism at play from insect 
vector to end point-host is highly suggestive and warrants further study. 
Overall, the results showed significant changes in the transcriptome of Aedes albopictus 
mosquitoes after CHIKV infection, with identified genes involved in multiple cellular 
processes. This study, for the first time, examines differential gene expression at the 
midgut (the first critical barrier site) and head and thorax (dissemination site containing 
salivary glands) in infected mosquitoes. The outcomes can be utilized in determining 
potential pro-viral and antiviral host factors and in turn, will be helpful in reducing the 
high impact of CHIKV infections by targeting the vector, Ae. albopictus. 
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Appendices  
Appendix-I: List of Primers 
Primer Sequence 
CHIKV_E1_FOR AAGAGCGATGAACTGCGCCGTAG 
CHIKV_E1_REV CTGGTACCTCGCATGACATGTC 
AALF004300_D8_FOR CACGAACCGAACGGATATG 
AALF004300_D8_REV TTCTGCTGCTGCTGTTG 
AALF008354_D8_FOR CGTGTCCTTCTACCAAATCC 
AALF008354_D8_REV TCTTGCGCTTCAGCTTAC 
AALF011899_D8_FOR GCTCGATGCGAGATAAGAAG 
AALF011899_D8_REV CTCGGTATCTTCAACGGTAATC 
AALF012324_D8_FOR GGCACCATCAATAGGGTAAC 
AALF012324_D8_REV CCTTCGAGCCAAACTCTATG 
AALF012634_D8_FOR CGGGAGATTTACGAGGTTTC 
AALF012634_D8_REV GCGTTCTTCCCTTCATCTC 
AALF016505_D8_FOR GGAATGTGGCAATGTGAATAC 
AALF016505_D8_REV GATCACTCGATCGGCATAAG 
AALF016704_D8_FOR ACTGACGTTCCCTTCAAAC 
AALF016704_D8_REV GCTCGATCGACTTCATCTTC 
AALF021910_D8_FOR GTGAACCTCATTCCGGATAC 
AALF021910_D8_REV CTTTCACCTCGGTCCAATC 
AALF023547_D8_FOR GAACCATCGTGGAAGAAGAG 
AALF023547_D8_REV CATCAGCTTCAGAGCCATATC 
AALF025245_D8_FOR CGGAGAAGCAGTTGGTATTC 
AALF025245_D8_REV CGATCGAGTGGAAGTCTTTG 
AALF026574_D8_FOR GAGGTGCTCGTTACATCTTG 
AALF026574_D8_REV GCAATGGGTGGTACCTTATC 
DN129476_D8_FOR GTGCTCTTCCGATCTTTCTC 
DN129476_D8_REV GAAGGTATCGTCGAGTTCAAG 
DN131737_D8_FOR GGGTCTTGAGCGAATGTATC 
DN131737_D8_REV TGCCGCATACTTGTAGTTATC 
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DN131885_D8_FOR ACTCTGGTGTACCCTTATCC 
DN131885_D8_REV TTCCTAGTGGTAGTGATCGAG 
AALF020406_D2_FOR GTACGATAGGACAGCCAAAC 
AALF020406_D2_REV GTCTCCTTTCTCCCGATTTG 
DN102975_D2_FOR GAATTGTGCGTACGATTTGG 
DN102975_D2_REV GGTGCATGGTGTATGAAATTG 
DN109582_D2_FOR GGAGAAGAGCTATCCACCTATC 
DN109582_D2_REV TTCCCTTGCACACTGAAAC 
DN109663_D2_FOR TCCGTTACTTCGGTTGATTG 
DN109663_D2_REV ATGCCACAGATCCTGAAAC 
DN110186_D2_FOR CATGGATCAACTCGGAGATTC 
DN110186_D2_REV ATCTCCTCTTCCCGCTTAC 
DN110327_D2_FOR ACACACGCCTCGCTGATATG 
DN110327_D2_REV AAGATCAATAGGGAAATTTCAAAGC 
DN110556_D2_FOR CATCGCCTACTACGTGATTC 
DN110556_D2_REV GCAAATGACCGTCCAAATG 
DN46100_D2_FOR CACGCGAATACGTTAAATTCC 
DN46100_D2_REV ATTTCGCAGCACAATTTCAG 
18srRNA_Fwd CGGCTACCACATCCAAGGAA 
18srRNA_Rev GCTGGAATTACCGCGGCT 
Aegypti_D2_Mucin_qPCR_FOR CTCAAACGGAGACCTCAAGC 
Aegypti_D2_Mucin_qPCR_REV TGGGTCGTCTCGGTAGAATC 
Aegypti_D2_NPCV2_qPCR_FOR TAGTTCCGGTCAAGGAATGC 
Aegypti_D2_NPCV2_qPCR_REV TCGCTGACACTGAAGTCCAC 
Aegypti_D2_DN110556_qPCR_FOR CTGAAATGTCCAGGATGTGC 
Aegypti_D2_DN110556_qPCR_REV GCATTTCGGTCAGCTTCTTC 
Aegypti_D2_DN110186_qPCR_FOR ACGGAATTCACCCTGAAGTG 
Aegypti_D2_DN110186_qPCR_REV CCAGCTGACCTGGTACTTGC 
Aegypti_D2_DN102975_qPCR_FOR TAGCGTTTGGGAGCACCTAC 
Aegypti_D2_DN102975_qPCR_REV CGACAGATTCACGTGTTTGG 
Aegypti_D2_DN46100_qPCR_FOR TGAACGATCCGGACTTTAGC 
Aegypti_D2_DN46100_qPCR_REV GCCCACAGCATTAGGAGAAC 
Aegypti_D2_DN110327_qPCR_FOR ACAGGCACCTGGTGGTAAAG 
Aegypti_D2_DN110327_qPCR_REV CGAATGGCTTCTTCTGGAAC 
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AALF004300_D8_FOR CACGAACCGAACGGATATG 
AALF004300_D8_REV TTCTGCTGCTGCTGTTG 
AALF008354_D8_FOR CGTGTCCTTCTACCAAATCC 
AALF008354_D8_REV TCTTGCGCTTCAGCTTAC 
AALF011899_D8_FOR GCTCGATGCGAGATAAGAAG 
AALF011899_D8_REV CTCGGTATCTTCAACGGTAATC 
AALF012324_D8_FOR GGCACCATCAATAGGGTAAC 
AALF012324_D8_REV CCTTCGAGCCAAACTCTATG 
AALF012634_D8_FOR CGGGAGATTTACGAGGTTTC 
AALF012634_D8_REV GCGTTCTTCCCTTCATCTC 
AALF016505_D8_FOR GGAATGTGGCAATGTGAATAC 
AALF016505_D8_REV GATCACTCGATCGGCATAAG 
AALF016704_D8_FOR ACTGACGTTCCCTTCAAAC 
AALF016704_D8_REV GCTCGATCGACTTCATCTTC 
AALF021910_D8_FOR GTGAACCTCATTCCGGATAC 
AALF021910_D8_REV CTTTCACCTCGGTCCAATC 
AALF023547_D8_FOR GAACCATCGTGGAAGAAGAG 
AALF023547_D8_REV CATCAGCTTCAGAGCCATATC 
AALF025245_D8_FOR CGGAGAAGCAGTTGGTATTC 
AALF025245_D8_REV CGATCGAGTGGAAGTCTTTG 
AALF026574_D8_FOR GAGGTGCTCGTTACATCTTG 
AALF026574_D8_REV GCAATGGGTGGTACCTTATC 
DN129476_D8_FOR GTGCTCTTCCGATCTTTCTC 
DN129476_D8_REV GAAGGTATCGTCGAGTTCAAG 
DN131737_D8_FOR GGGTCTTGAGCGAATGTATC 
DN131737_D8_REV TGCCGCATACTTGTAGTTATC 
DN131885_D8_FOR ACTCTGGTGTACCCTTATCC 
DN131885_D8_REV TTCCTAGTGGTAGTGATCGAG 
BTKi_dsRNA_FWD 
GTCATAATACGACTCACTATA 
GGGAGATGTTCACGATTTGAGCTTCG 
BTKi_dsRNA_REV 
GTCATAATACGACTCACTATA 
GGGAGAAGATCTGGGTAGGCATCACG 
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Appendix-II: List of differentially expressed genes D2_DESeq2 
GeneID Base mean log2(FC) StdErr Wald-Stats P-value P-adj 
AALF020406 216.7005 -5.56282 0.685547 -8.11442 4.88E-16 3.93E-12 
AALF012050 1919.848 4.968855 0.636043 7.81214 5.62E-15 2.26E-11 
AALF005925 207.2692 3.431226 0.651706 5.264988 1.40E-07 0.000376 
AALF016850 231.3505 -3.54486 0.725066 -4.88902 1.01E-06 0.002041 
AALF015699 7062.463 -1.42751 0.300412 -4.75183 2.02E-06 0.002676 
AALF029854 1722.729 -2.01367 0.423985 -4.74939 2.04E-06 0.002676 
AALF027085 111.1469 3.373469 0.714286 4.722851 2.33E-06 0.002676 
AALF020983 177.9063 2.950483 0.633377 4.658338 3.19E-06 0.00321 
AALF025203 2013.3 2.431263 0.532464 4.566061 4.97E-06 0.004448 
AALF023645 111.604 3.059275 0.68506 4.465701 7.98E-06 0.006429 
AALF001554 621.3091 -2.5475 0.574526 -4.4341 9.25E-06 0.006771 
AALF015302 90.97449 3.104544 0.707611 4.387361 1.15E-05 0.007702 
AALF027756 87.29894 -3.15954 0.725976 -4.35212 1.35E-05 0.008355 
AALF013306 11931.84 -1.33999 0.310066 -4.32162 1.55E-05 0.008913 
AALF004977 74.09452 -3.04832 0.726769 -4.19435 2.74E-05 0.014697 
AALF027007 104.2738 -3.02727 0.726324 -4.16794 3.07E-05 0.015476 
AALF019954 824.7693 2.425737 0.601446 4.033177 5.50E-05 0.026077 
AALF018103 231.8302 2.538813 0.631615 4.019556 5.83E-05 0.026096 
AALF016689 108.2655 2.779222 0.701054 3.964346 7.36E-05 0.030833 
AALF019776 171.4389 -2.86038 0.723238 -3.95496 7.65E-05 0.030833 
AALF011874 1818.249 -1.79901 0.459684 -3.91357 9.09E-05 0.034887 
AALF006972 2730.712 1.85584 0.483838 3.835662 0.000125 0.045856 
AALF028549 98.38542 2.674245 0.70129 3.813325 0.000137 0.047312 
AALF002386 5133.129 1.815648 0.476986 3.806499 0.000141 0.047312 
AALF002948 78.91971 2.741821 0.724579 3.784018 0.000154 0.049727 
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Appendix-III: List of differentially expressed genes D2_edgeR 
  sampleA sampleB logFC logCPM PValue FDR 
TRINITY_DN109499_c0_g1_i3 Infected Control -12.7616 8.430899 2.02E-05 0.190876 
TRINITY_DN110715_c0_g3_i4 Infected Control -11.8975 7.573359 3.31E-05 0.190876 
TRINITY_DN110618_c0_g4_i1 Infected Control -9.66854 7.9446 4.61E-05 0.190876 
TRINITY_DN110359_c0_g2_i1 Infected Control 13.73885 9.987767 7.31E-05 0.190876 
TRINITY_DN110550_c0_g1_i2 Infected Control -11.2601 6.944009 7.98E-05 0.190876 
TRINITY_DN109503_c0_g1_i4 Infected Control -11.2246 6.909069 9.75E-05 0.190876 
TRINITY_DN110110_c1_g1_i3 Infected Control -11.6396 7.318323 0.000118 0.190876 
TRINITY_DN109499_c0_g1_i4 Infected Control -11.348 7.030502 0.000131 0.190876 
TRINITY_DN110262_c1_g1_i1 Infected Control -11.0003 6.688622 0.000136 0.190876 
TRINITY_DN105366_c0_g2_i1 Infected Control -11.3263 7.009193 0.000212 0.268567 
TRINITY_DN109947_c0_g1_i1 Infected Control -12.7254 8.394923 0.000267 0.307055 
TRINITY_DN106892_c0_g2_i1 Infected Control -9.36271 9.497906 0.000351 0.370504 
TRINITY_DN102795_c0_g1_i1 Infected Control -11.0194 10.88318 0.00044 0.42887 
TRINITY_DN110978_c0_g1_i1 Infected Control -10.5981 6.294992 0.000506 0.458151 
TRINITY_DN110618_c0_g4_i4 Infected Control -7.60732 10.99402 0.000638 0.535413 
TRINITY_DN98669_c0_g1_i1 Infected Control -10.4076 6.109418 0.000716 0.535413 
TRINITY_DN110626_c1_g2_i2 Infected Control -8.08592 13.67002 0.000719 0.535413 
TRINITY_DN110668_c0_g1_i4 Infected Control 8.991747 9.041062 0.000783 0.550719 
TRINITY_DN110359_c0_g1_i1 Infected Control 9.482928 8.968226 0.000872 0.581177 
TRINITY_DN7727_c0_g1_i1 Infected Control -9.96207 5.678356 0.001151 0.706028 
TRINITY_DN66099_c0_g1_i1 Infected Control -9.96078 5.677108 0.00117 0.706028 
TRINITY_DN110644_c0_g2_i4 Infected Control 11.15353 7.41591 0.001346 0.775103 
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TRINITY_DN109361_c0_g1_i1 Infected Control -8.35051 5.936438 0.001447 0.797185 
TRINITY_DN110615_c1_g2_i3 Infected Control -6.7219 12.12704 0.001797 0.948666 
TRINITY_DN70601_c0_g1_i1 Infected Control -9.79709 5.519885 0.002032 1 
TRINITY_DN107541_c0_g3_i1 Infected Control -10.0542 5.767183 0.002079 1 
TRINITY_DN109864_c0_g3_i4 Infected Control -9.63972 5.369456 0.002412 1 
TRINITY_DN110340_c1_g1_i1 Infected Control 10.95759 10.46041 0.002537 1 
TRINITY_DN106892_c0_g1_i1 Infected Control -8.3369 8.53023 0.002691 1 
TRINITY_DN109947_c1_g2_i1 Infected Control -9.55996 5.293497 0.00279 1 
TRINITY_DN71695_c0_g2_i1 Infected Control -9.98845 7.427299 0.003052 1 
TRINITY_DN110349_c1_g1_i1 Infected Control -9.53068 5.265663 0.003112 1 
TRINITY_DN110698_c0_g4_i1 Infected Control 9.989153 10.38533 0.003431 1 
TRINITY_DN109913_c0_g1_i1 Infected Control -9.46198 5.200464 0.003942 1 
TRINITY_DN109965_c0_g1_i1 Infected Control 11.1866 10.71399 0.003953 1 
TRINITY_DN110478_c1_g8_i1 Infected Control 10.546 6.816766 0.004061 1 
TRINITY_DN110734_c0_g3_i6 Infected Control 8.469432 7.119743 0.004169 1 
TRINITY_DN101711_c0_g1_i1 Infected Control -9.53386 5.26871 0.004228 1 
TRINITY_DN110482_c0_g1_i2 Infected Control -9.42264 5.163213 0.004661 1 
TRINITY_DN110618_c0_g5_i2 Infected Control -7.86449 5.368206 0.004742 1 
TRINITY_DN107831_c0_g1_i1 Infected Control -7.59204 10.73823 0.004821 1 
TRINITY_DN110961_c0_g1_i1 Infected Control -8.1769 5.76101 0.005107 1 
TRINITY_DN110478_c1_g8_i7 Infected Control 9.998378 6.280422 0.00581 1 
TRINITY_DN110581_c0_g1_i1 Infected Control 9.839772 6.1261 0.006083 1 
TRINITY_DN110623_c0_g1_i6 Infected Control -7.85675 5.359162 0.006151 1 
TRINITY_DN110632_c1_g1_i1 Infected Control 8.001935 6.660377 0.006763 1 
TRINITY_DN70511_c0_g1_i1 Infected Control -8.9438 6.400187 0.007159 1 
TRINITY_DN110359_c0_g3_i2 Infected Control 7.160582 8.688477 0.007316 1 
TRINITY_DN110536_c1_g2_i1 Infected Control -9.27195 5.02097 0.00734 1 
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TRINITY_DN110294_c0_g2_i1 Infected Control 9.83506 6.121448 0.007711 1 
TRINITY_DN110096_c1_g1_i2 Infected Control -6.95361 11.30214 0.007838 1 
TRINITY_DN110535_c0_g3_i1 Infected Control -9.26501 5.014488 0.007867 1 
TRINITY_DN110208_c0_g2_i2 Infected Control 9.556247 5.850988 0.00799 1 
TRINITY_DN110064_c0_g3_i1 Infected Control -7.4586 9.790717 0.008066 1 
TRINITY_DN110615_c1_g1_i1 Infected Control -9.22937 4.980935 0.008186 1 
TRINITY_DN106957_c0_g2_i1 Infected Control 9.548651 5.843636 0.008565 1 
TRINITY_DN109371_c0_g1_i1 Infected Control 8.71272 10.90362 0.009033 1 
TRINITY_DN102757_c0_g1_i1 Infected Control -9.16505 4.920623 0.009716 1 
TRINITY_DN109482_c0_g1_i2 Infected Control -5.08001 7.442615 0.010561 1 
TRINITY_DN108974_c1_g1_i1 Infected Control -9.1188 4.877328 0.011452 1 
TRINITY_DN110340_c1_g1_i4 Infected Control -8.4797 5.948287 0.011716 1 
TRINITY_DN110698_c0_g4_i2 Infected Control 10.09598 6.375815 0.011763 1 
TRINITY_DN82039_c0_g1_i1 Infected Control -9.14783 4.904554 0.011865 1 
TRINITY_DN107626_c1_g1_i1 Infected Control -9.09941 4.8592 0.012388 1 
TRINITY_DN109177_c0_g1_i2 Infected Control 10.12008 10.85761 0.012657 1 
TRINITY_DN109466_c0_g1_i1 Infected Control 11.04908 7.312752 0.012914 1 
TRINITY_DN110096_c1_g1_i5 Infected Control -5.75002 12.12155 0.013141 1 
TRINITY_DN71695_c0_g1_i1 Infected Control -5.79248 6.926392 0.013334 1 
TRINITY_DN110447_c0_g4_i5 Infected Control -4.73961 10.83299 0.01335 1 
TRINITY_DN110327_c1_g2_i1 Infected Control -9.07566 4.837083 0.013518 1 
TRINITY_DN110644_c0_g1_i4 Infected Control -7.51061 5.029009 0.013529 1 
TRINITY_DN108275_c0_g1_i2 Infected Control -9.04557 4.809027 0.014382 1 
TRINITY_DN30821_c0_g1_i1 Infected Control -9.044 4.807534 0.014436 1 
TRINITY_DN109837_c0_g3_i1 Infected Control -9.05618 4.818862 0.014529 1 
TRINITY_DN110054_c0_g2_i4 Infected Control -9.07522 4.836597 0.014973 1 
TRINITY_DN109298_c0_g2_i1 Infected Control -9.02046 4.785618 0.015485 1 
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TRINITY_DN110226_c0_g1_i1 Infected Control 9.153406 5.463419 0.015567 1 
TRINITY_DN46100_c0_g1_i1 Infected Control -9.0398 4.803693 0.016024 1 
TRINITY_DN93544_c0_g1_i1 Infected Control -7.35726 4.985668 0.016188 1 
TRINITY_DN107528_c0_g1_i1 Infected Control 10.04045 6.321596 0.016215 1 
TRINITY_DN110206_c0_g1_i3 Infected Control 6.99942 6.513863 0.016342 1 
TRINITY_DN34439_c0_g1_i1 Infected Control -8.99019 4.75749 0.016805 1 
TRINITY_DN110609_c0_g2_i1 Infected Control 7.237429 5.916179 0.016972 1 
TRINITY_DN110359_c0_g3_i3 Infected Control 6.435098 6.863692 0.017189 1 
TRINITY_DN109582_c0_g2_i2 Infected Control 6.293482 7.511639 0.01757 1 
TRINITY_DN110629_c0_g1_i12 Infected Control -8.98053 4.748479 0.017602 1 
TRINITY_DN109591_c1_g3_i1 Infected Control -6.31606 5.150155 0.017701 1 
TRINITY_DN103661_c0_g1_i2 Infected Control 9.095576 5.408016 0.017739 1 
TRINITY_DN109587_c0_g1_i2 Infected Control 9.869614 6.155106 0.017753 1 
TRINITY_DN109503_c0_g1_i1 Infected Control -8.98308 4.750845 0.017767 1 
TRINITY_DN105467_c0_g2_i1 Infected Control 9.794479 6.082038 0.018058 1 
TRINITY_DN107366_c0_g1_i1 Infected Control -8.96343 4.73262 0.018169 1 
TRINITY_DN110715_c0_g1_i1 Infected Control -7.33712 4.980619 0.018271 1 
TRINITY_DN93300_c0_g1_i1 Infected Control 9.091768 5.404624 0.01887 1 
TRINITY_DN110335_c0_g1_i1 Infected Control 7.436466 6.964125 0.018877 1 
TRINITY_DN111483_c0_g1_i1 Infected Control -8.94651 4.716971 0.018884 1 
TRINITY_DN110048_c0_g2_i2 Infected Control 9.893599 6.178449 0.019109 1 
TRINITY_DN107799_c0_g1_i1 Infected Control -8.93759 4.708696 0.019409 1 
TRINITY_DN108666_c0_g1_i2 Infected Control 9.4239 9.851114 0.019411 1 
TRINITY_DN110555_c0_g1_i4 Infected Control 10.67724 6.945991 0.019511 1 
TRINITY_DN110389_c3_g1_i3 Infected Control -8.98271 4.750472 0.019874 1 
TRINITY_DN108374_c0_g1_i2 Infected Control 10.37738 6.651305 0.019988 1 
TRINITY_DN109529_c0_g1_i2 Infected Control -8.93732 4.708474 0.020288 1 
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TRINITY_DN109797_c0_g1_i1 Infected Control -8.97209 4.740601 0.020904 1 
TRINITY_DN109479_c0_g3_i1 Infected Control 10.24209 6.518662 0.020993 1 
TRINITY_DN94065_c0_g2_i1 Infected Control -8.93402 4.705428 0.020995 1 
TRINITY_DN18793_c0_g1_i1 Infected Control -8.94275 4.713392 0.021348 1 
TRINITY_DN109483_c0_g1_i1 Infected Control 8.969289 5.287781 0.02184 1 
TRINITY_DN110564_c0_g3_i4 Infected Control 11.8454 8.101679 0.022012 1 
TRINITY_DN108555_c0_g1_i1 Infected Control -8.90675 4.680084 0.022025 1 
TRINITY_DN110299_c3_g7_i2 Infected Control 9.174141 5.483453 0.022133 1 
TRINITY_DN108042_c0_g2_i1 Infected Control 8.975135 5.293381 0.022339 1 
TRINITY_DN110478_c1_g8_i4 Infected Control 6.610936 6.654722 0.022912 1 
TRINITY_DN110384_c0_g2_i4 Infected Control 10.09482 6.374674 0.02327 1 
TRINITY_DN109700_c0_g1_i2 Infected Control 8.949018 5.268452 0.023654 1 
TRINITY_DN109594_c0_g3_i1 Infected Control 8.933362 5.25368 0.023751 1 
TRINITY_DN102147_c0_g1_i1 Infected Control -6.66549 5.091573 0.024044 1 
TRINITY_DN108353_c0_g1_i1 Infected Control 8.974094 5.292517 0.024065 1 
TRINITY_DN107988_c0_g1_i1 Infected Control 10.09141 6.371332 0.024261 1 
TRINITY_DN109115_c0_g2_i1 Infected Control 10.03894 6.320102 0.024517 1 
TRINITY_DN68277_c0_g1_i1 Infected Control -8.86361 4.640263 0.024552 1 
TRINITY_DN110276_c0_g1_i4 Infected Control 9.282878 5.587416 0.024955 1 
TRINITY_DN107618_c0_g2_i1 Infected Control -8.86667 4.64304 0.025032 1 
TRINITY_DN106868_c0_g1_i1 Infected Control -8.87202 4.64808 0.025365 1 
TRINITY_DN110505_c0_g1_i1 Infected Control -4.46245 6.521945 0.025825 1 
TRINITY_DN109849_c0_g1_i2 Infected Control 6.006359 6.446461 0.025962 1 
TRINITY_DN110141_c0_g2_i2 Infected Control 6.081557 5.650486 0.026158 1 
TRINITY_DN110368_c2_g3_i2 Infected Control -8.83832 4.616927 0.026426 1 
TRINITY_DN109578_c1_g1_i1 Infected Control -4.62029 7.946849 0.026814 1 
TRINITY_DN110544_c0_g1_i1 Infected Control 6.289405 5.871812 0.026868 1 
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TRINITY_DN109280_c0_g1_i1 Infected Control -8.83861 4.617157 0.027004 1 
TRINITY_DN110368_c2_g1_i3 Infected Control -5.16371 6.305765 0.027163 1 
TRINITY_DN109743_c0_g1_i1 Infected Control -8.83367 4.612613 0.027252 1 
TRINITY_DN107936_c1_g1_i1 Infected Control -8.85427 4.631719 0.02738 1 
TRINITY_DN106859_c0_g2_i1 Infected Control -8.8287 4.608054 0.02743 1 
TRINITY_DN110058_c0_g1_i3 Infected Control -8.83195 4.611082 0.027474 1 
TRINITY_DN110673_c0_g1_i5 Infected Control 8.938259 5.258143 0.027663 1 
TRINITY_DN110431_c1_g1_i7 Infected Control -7.40144 5.63649 0.027811 1 
TRINITY_DN110536_c1_g2_i2 Infected Control 8.853601 5.17801 0.027847 1 
TRINITY_DN110335_c0_g1_i2 Infected Control -8.82769 4.607171 0.027878 1 
TRINITY_DN109430_c0_g2_i2 Infected Control 6.774976 5.472487 0.028048 1 
TRINITY_DN109818_c0_g3_i1 Infected Control 6.831968 5.559898 0.028409 1 
TRINITY_DN110348_c2_g1_i1 Infected Control -3.88229 9.090205 0.028522 1 
TRINITY_DN12857_c0_g2_i1 Infected Control -8.83236 4.611502 0.028605 1 
TRINITY_DN103631_c0_g1_i1 Infected Control -8.83397 4.612843 0.028989 1 
TRINITY_DN108633_c1_g2_i1 Infected Control -8.83024 4.609549 0.029272 1 
TRINITY_DN110447_c0_g4_i6 Infected Control 9.167764 5.477299 0.029333 1 
TRINITY_DN110729_c1_g4_i1 Infected Control -8.82128 4.601287 0.029415 1 
TRINITY_DN108758_c0_g2_i1 Infected Control -8.82953 4.608898 0.029482 1 
TRINITY_DN109657_c0_g2_i1 Infected Control 9.159982 5.469867 0.029706 1 
TRINITY_DN59519_c0_g1_i1 Infected Control 6.909128 10.85333 0.029871 1 
TRINITY_DN110632_c1_g1_i7 Infected Control 4.829759 8.495025 0.030089 1 
TRINITY_DN57758_c0_g1_i1 Infected Control -8.81699 4.59735 0.030476 1 
TRINITY_DN110404_c0_g1_i2 Infected Control 5.854872 6.299851 0.030532 1 
TRINITY_DN110596_c0_g1_i6 Infected Control 8.177442 10.48818 0.030781 1 
TRINITY_DN93575_c0_g2_i1 Infected Control 9.726356 6.015839 0.030961 1 
TRINITY_DN95908_c0_g2_i1 Infected Control 8.832378 5.157822 0.03099 1 
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TRINITY_DN103962_c0_g1_i1 Infected Control 9.891431 6.176274 0.031209 1 
TRINITY_DN110066_c0_g5_i1 Infected Control -8.77976 4.563049 0.03146 1 
TRINITY_DN110186_c0_g1_i2 Infected Control 8.823672 5.149679 0.031707 1 
TRINITY_DN111536_c0_g1_i1 Infected Control -8.80454 4.585744 0.031725 1 
TRINITY_DN110556_c0_g2_i1 Infected Control 8.843942 5.168931 0.031835 1 
TRINITY_DN104438_c0_g1_i1 Infected Control 8.905135 5.226899 0.03199 1 
TRINITY_DN67465_c0_g1_i1 Infected Control -8.77154 4.555424 0.032862 1 
TRINITY_DN107477_c0_g1_i1 Infected Control -8.75188 4.537498 0.035011 1 
TRINITY_DN110558_c6_g1_i1 Infected Control 8.486349 7.171751 0.035082 1 
TRINITY_DN110582_c0_g1_i4 Infected Control 4.915382 8.292741 0.035569 1 
TRINITY_DN110751_c0_g8_i2 Infected Control 9.555462 5.850287 0.036044 1 
TRINITY_DN110081_c0_g1_i2 Infected Control 5.875045 5.995031 0.036213 1 
TRINITY_DN110632_c1_g2_i8 Infected Control 5.558413 7.580493 0.036329 1 
TRINITY_DN106947_c0_g1_i1 Infected Control 9.658076 5.949607 0.036584 1 
TRINITY_DN110582_c0_g3_i1 Infected Control 10.78809 7.055172 0.036659 1 
TRINITY_DN110492_c2_g4_i1 Infected Control -8.75208 4.537523 0.036772 1 
TRINITY_DN108203_c0_g2_i1 Infected Control -5.53849 5.406491 0.036818 1 
TRINITY_DN108635_c0_g3_i1 Infected Control 8.794653 5.12213 0.036995 1 
TRINITY_DN110404_c0_g1_i5 Infected Control 8.712048 5.044282 0.037186 1 
TRINITY_DN98700_c0_g1_i1 Infected Control -3.95773 7.611426 0.037506 1 
TRINITY_DN99324_c0_g1_i1 Infected Control -8.71412 4.502882 0.037591 1 
TRINITY_DN110040_c0_g2_i2 Infected Control 8.691967 5.025354 0.03804 1 
TRINITY_DN110626_c1_g2_i3 Infected Control -5.51192 12.62003 0.038159 1 
TRINITY_DN110611_c0_g1_i2 Infected Control 8.800087 5.127212 0.03822 1 
TRINITY_DN102975_c0_g1_i1 Infected Control -8.70164 4.491396 0.038288 1 
TRINITY_DN105968_c0_g1_i1 Infected Control -8.71027 4.499373 0.038364 1 
TRINITY_DN110427_c1_g3_i1 Infected Control -8.69976 4.489742 0.038862 1 
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TRINITY_DN110587_c0_g1_i2 Infected Control 6.056915 5.649862 0.038974 1 
TRINITY_DN110711_c2_g5_i2 Infected Control -8.70718 4.496559 0.039262 1 
TRINITY_DN110388_c3_g1_i1 Infected Control 8.936717 5.256943 0.039446 1 
TRINITY_DN109717_c0_g2_i1 Infected Control -8.69185 4.482422 0.039715 1 
TRINITY_DN60479_c0_g2_i1 Infected Control -8.68323 4.474579 0.040025 1 
TRINITY_DN107374_c0_g1_i1 Infected Control 8.672526 5.007057 0.040128 1 
TRINITY_DN110714_c4_g1_i1 Infected Control -8.68683 4.477908 0.040308 1 
TRINITY_DN17942_c0_g1_i1 Infected Control 9.678862 5.96975 0.040893 1 
TRINITY_DN110083_c0_g2_i2 Infected Control -3.46395 9.523147 0.040965 1 
TRINITY_DN108909_c1_g5_i1 Infected Control 8.657743 4.99312 0.042061 1 
TRINITY_DN109499_c0_g1_i5 Infected Control -5.28902 8.883271 0.042289 1 
TRINITY_DN110708_c0_g1_i6 Infected Control -3.53987 12.92877 0.042794 1 
TRINITY_DN110461_c1_g4_i1 Infected Control -7.12678 4.665034 0.042935 1 
TRINITY_DN109674_c0_g2_i1 Infected Control -8.67286 4.465022 0.043047 1 
TRINITY_DN110708_c0_g1_i5 Infected Control 6.566762 9.285918 0.043609 1 
TRINITY_DN110791_c0_g1_i1 Infected Control -8.63585 4.431293 0.044583 1 
TRINITY_DN94102_c0_g2_i1 Infected Control 9.388931 5.689582 0.044584 1 
TRINITY_DN107926_c0_g1_i1 Infected Control 8.700916 5.033715 0.045406 1 
TRINITY_DN109837_c0_g2_i1 Infected Control -8.62526 4.421687 0.045469 1 
TRINITY_DN109985_c1_g1_i2 Infected Control 5.365848 6.185328 0.045714 1 
TRINITY_DN108118_c0_g2_i1 Infected Control -6.95359 4.630653 0.045839 1 
TRINITY_DN109159_c0_g1_i1 Infected Control -8.6228 4.419462 0.045876 1 
TRINITY_DN110410_c0_g2_i3 Infected Control 8.6888 5.022249 0.045949 1 
TRINITY_DN110663_c0_g2_i3 Infected Control 9.293455 5.597688 0.046509 1 
TRINITY_DN110627_c0_g2_i1 Infected Control 8.239354 10.93808 0.047002 1 
TRINITY_DN109180_c0_g1_i2 Infected Control -5.11271 5.601466 0.047002 1 
TRINITY_DN41428_c0_g1_i1 Infected Control -8.60418 4.402533 0.047435 1 
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TRINITY_DN110369_c0_g2_i1 Infected Control 5.884735 5.486452 0.047537 1 
TRINITY_DN108287_c0_g1_i1 Infected Control -5.43029 5.308833 0.047609 1 
TRINITY_DN102237_c0_g3_i1 Infected Control -8.61753 4.414754 0.047841 1 
TRINITY_DN67064_c0_g1_i1 Infected Control -8.60881 4.406786 0.047852 1 
TRINITY_DN110505_c0_g1_i5 Infected Control 4.933306 6.566355 0.048208 1 
TRINITY_DN93199_c0_g1_i1 Infected Control -8.60453 4.40278 0.048501 1 
TRINITY_DN108621_c1_g1_i2 Infected Control -8.60466 4.403037 0.048702 1 
TRINITY_DN101006_c0_g2_i1 Infected Control -8.63807 4.433502 0.048889 1 
TRINITY_DN107887_c0_g1_i1 Infected Control 9.187912 5.496523 0.04911 1 
TRINITY_DN14104_c0_g1_i1 Infected Control -8.59036 4.389956 0.049153 1 
TRINITY_DN109663_c0_g2_i1 Infected Control -8.61033 4.408028 0.049355 1 
TRINITY_DN66460_c0_g1_i1 Infected Control 8.590316 4.929804 0.049468 1 
TRINITY_DN95571_c0_g1_i1 Infected Control -6.94967 4.627481 0.049522 1 
TRINITY_DN110576_c0_g1_i6 Infected Control -6.22733 4.61703 0.049842 1 
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Appendix-IV: List of differentially expressed genes D8_DESeq2 
GeneID Base mean log2(FC) StdErr Wald-Stats P-value P-adj 
AALF003125 309.0048 -6.66141 0.67967 -9.80093 1.12E-22 1.08E-18 
AALF029552 8380.408 -2.35 0.33893 -6.93356 4.10E-12 1.99E-08 
AALF025212 3667.483 -2.39687 0.35417 -6.76755 1.31E-11 4.23E-08 
AALF016811 209.9323 4.56912 0.71365 6.402476 1.53E-10 3.70E-07 
AALF008821 123.3598 -4.65933 0.75399 -6.17957 6.43E-10 1.24E-06 
AALF010140 254.9795 4.38865 0.72404 6.061328 1.35E-09 2.18E-06 
AALF005487 112.1111 -4.5298 0.76903 -5.89025 3.86E-09 5.33E-06 
AALF008822 2089.474 -2.19608 0.40992 -5.35738 8.44E-08 0.0001 
AALF029926 49567.17 -1.60162 0.30735 -5.21106 1.88E-07 0.0002 
AALF022468 148.3781 3.81626 0.74179 5.144653 2.68E-07 0.00026 
AALF026213 142.0296 3.71553 0.74532 4.985161 6.19E-07 0.00055 
AALF019949 82.3505 -3.82794 0.7777 -4.92214 8.56E-07 0.00069 
AALF020653 105.2114 -3.71868 0.75987 -4.89383 9.89E-07 0.00074 
AALF022699 1523.225 -2.00222 0.4146 -4.82931 1.37E-06 0.00085 
AALF012050 208.9281 3.41336 0.70741 4.825147 1.40E-06 0.00085 
AALF013568 224.4647 3.63772 0.75091 4.844416 1.27E-06 0.00085 
AALF028390 16105.77 -1.5781 0.33046 -4.7755 1.79E-06 0.00102 
AALF021910 140.6905 3.54935 0.75137 4.723817 2.31E-06 0.00121 
AALF020193 196.0018 -3.27061 0.69316 -4.7184 2.38E-06 0.00121 
AALF018314 241.1632 3.13224 0.66827 4.687073 2.77E-06 0.00134 
AALF012634 142.7464 3.50692 0.75295 4.657567 3.20E-06 0.00148 
AALF012608 1312.558 1.92944 0.42386 4.55211 5.31E-06 0.00227 
AALF000424 189.7795 3.22009 0.70795 4.548497 5.40E-06 0.00227 
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AALF006357 141.1417 3.35025 0.73877 4.534891 5.76E-06 0.00233 
AALF013462 281.9295 -2.8146 0.6245 -4.50696 6.58E-06 0.00255 
AALF001478 1468.268 -1.9102 0.42606 -4.48346 7.34E-06 0.00274 
AALF000044 1946.213 -2.00581 0.45053 -4.45216 8.50E-06 0.00294 
AALF023808 504.7657 -2.45833 0.55124 -4.45964 8.21E-06 0.00294 
AALF004653 133.4889 3.22406 0.74435 4.331375 1.48E-05 0.00495 
AALF026733 84.07934 -3.33885 0.78091 -4.2756 1.91E-05 0.00615 
AALF022003 66.79487 -3.31525 0.78043 -4.24801 2.16E-05 0.00633 
AALF009184 126.5829 3.20588 0.75393 4.252206 2.12E-05 0.00633 
AALF029294 12557.35 -1.53858 0.36216 -4.24834 2.15E-05 0.00633 
AALF005682 119.5524 3.19284 0.75368 4.236351 2.27E-05 0.00647 
AALF019283 142.6499 3.09315 0.73407 4.213692 2.51E-05 0.00657 
AALF029751 1675.971 -1.77416 0.42046 -4.21958 2.45E-05 0.00657 
AALF027705 112.9815 3.20909 0.76156 4.213869 2.51E-05 0.00657 
AALF013811 116.7863 3.20266 0.76191 4.20348 2.63E-05 0.0067 
AALF013936 218.1549 2.81212 0.67384 4.173302 3.00E-05 0.00745 
AALF009808 733.2235 2.12522 0.51141 4.15564 3.24E-05 0.00783 
AALF010472 136.42 -3.02563 0.72894 -4.15074 3.31E-05 0.00783 
AALF007409 129.3108 3.08945 0.75066 4.115619 3.86E-05 0.0089 
AALF030003 18609.42 -1.55019 0.379 -4.09021 4.31E-05 0.00908 
AALF004949 115.1153 3.09592 0.75721 4.088606 4.34E-05 0.00908 
AALF006290 225.9239 -2.98518 0.73163 -4.08016 4.50E-05 0.00908 
AALF018602 119.851 3.09499 0.75777 4.084361 4.42E-05 0.00908 
AALF006216 534.9484 -2.20591 0.5401 -4.08427 4.42E-05 0.00908 
AALF004409 16064.4 -1.56286 0.38227 -4.08836 4.34E-05 0.00908 
AALF009483 121.1436 3.04588 0.75142 4.053519 5.05E-05 0.00997 
AALF026574 57.60346 -3.12196 0.77441 -4.03139 5.54E-05 0.01074 
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AALF026375 293.7806 2.50352 0.62393 4.01249 6.01E-05 0.01141 
AALF018616 207.0673 2.72475 0.68046 4.004284 6.22E-05 0.01158 
AALF017763 1563.739 -1.99175 0.49839 -3.99641 6.43E-05 0.01175 
AALF016614 137.5492 2.95747 0.74218 3.984852 6.75E-05 0.01211 
AALF029473 5904.79 -1.38429 0.34854 -3.97168 7.14E-05 0.01256 
AALF004741 131.5144 2.98495 0.75606 3.948065 7.88E-05 0.01362 
AALF012324 115.5417 2.96348 0.7545 3.927756 8.57E-05 0.01456 
AALF007640 102.035 2.98632 0.7677 3.889961 0.0001 0.01674 
AALF011696 63.36724 -3.0151 0.77867 -3.87213 0.00011 0.01741 
AALF002033 166.8618 -2.81255 0.72615 -3.87325 0.00011 0.01741 
AALF004300 1909.116 1.52921 0.39539 3.86758 0.00011 0.01745 
AALF010879 270.3014 2.45869 0.63808 3.85328 0.00012 0.0182 
AALF018416 203.4816 2.67494 0.69614 3.842541 0.00012 0.01861 
AALF029707 9303.243 -1.3865 0.36106 -3.84003 0.00012 0.01861 
AALF010650 53.90038 -2.9568 0.77095 -3.8353 0.00013 0.01868 
AALF022562 265.6455 2.47012 0.64851 3.808907 0.00014 0.02048 
AALF005662 135.9857 -2.7931 0.73739 -3.78785 0.00015 0.02196 
AALF020726 103.364 2.8865 0.764 3.778131 0.00016 0.02218 
AALF029966 79819.57 -1.21791 0.32236 -3.77807 0.00016 0.02218 
AALF018742 52.25456 -2.88133 0.76907 -3.7465 0.00018 0.0248 
AALF016505 1204.019 -1.64991 0.44845 -3.67915 0.00023 0.03075 
AALF018116 101.1572 2.8398 0.77145 3.68113 0.00023 0.03075 
AALF024478 2947.581 -1.3565 0.36841 -3.68206 0.00023 0.03075 
AALF028389 8508.116 -1.24092 0.33739 -3.67807 0.00024 0.03075 
AALF011899 185.0763 2.54016 0.69409 3.659686 0.00025 0.0326 
AALF008354 457.72 2.06779 0.56669 3.648908 0.00026 0.03355 
AALF002627 77.51303 -2.83372 0.77946 -3.63548 0.00028 0.03424 
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AALF003865 138.9563 2.76608 0.76061 3.636676 0.00028 0.03424 
AALF010018 770.8866 1.75411 0.4831 3.630927 0.00028 0.03424 
AALF029391 11838.58 -1.45831 0.40169 -3.63044 0.00028 0.03424 
AALF027402 1241.659 1.67924 0.46433 3.616523 0.0003 0.03569 
AALF012277 169.9871 -2.51851 0.69861 -3.60502 0.00031 0.03685 
AALF006068 106.1849 2.78284 0.77289 3.600578 0.00032 0.03697 
AALF012023 511.8153 2.11554 0.58798 3.597957 0.00032 0.03697 
AALF008589 95.82241 2.754 0.76785 3.586646 0.00034 0.03815 
AALF024589 118.8952 2.71411 0.75983 3.572004 0.00035 0.03988 
AALF015598 92.00105 2.74768 0.77336 3.552932 0.00038 0.0424 
AALF024585 93.7284 2.73652 0.77364 3.537185 0.0004 0.0445 
AALF006531 438.0126 -2.00926 0.56948 -3.52825 0.00042 0.045 
AALF014168 91.03864 2.73169 0.77369 3.530749 0.00041 0.045 
AALF019406 48.14003 -2.68713 0.76334 -3.52025 0.00043 0.04587 
AALF024475 47.72858 -2.66729 0.76267 -3.4973 0.00047 0.0479 
AALF000340 313.2052 2.14223 0.61207 3.499952 0.00047 0.0479 
AALF013313 144.1811 2.54665 0.72773 3.499426 0.00047 0.0479 
AALF029874 2598.481 -1.37886 0.39395 -3.50004 0.00047 0.0479 
AALF024243 188.1177 2.41145 0.69181 3.485717 0.00049 0.0495 
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Appendix-V: List of differentially expressed genes D8_edgeR 
  sampleA sampleB logFC logCPM PValue FDR 
TRINITY_DN132509_c0_g1_i1 Infected Control 12.9347 17.3283 1.87E-09 2.22E-05 
TRINITY_DN130280_c0_g1_i3 Infected Control -8.59884 7.66879 3.00E-09 2.22E-05 
TRINITY_DN132452_c0_g1_i1 Infected Control -7.2922 8.54038 2.05E-08 0.0001 
TRINITY_DN132014_c0_g1_i7 Infected Control -6.05734 7.3497 1.29E-06 0.00471 
TRINITY_DN131809_c1_g2_i5 Infected Control -6.49685 6.16019 1.59E-06 0.00471 
TRINITY_DN131737_c0_g1_i2 Infected Control -6.42244 6.09072 1.99E-06 0.00492 
TRINITY_DN121041_c0_g2_i1 Infected Control -6.47659 5.64515 3.67E-06 0.00588 
TRINITY_DN132229_c2_g4_i1 Infected Control -5.66949 7.34299 3.68E-06 0.00588 
TRINITY_DN119808_c0_g1_i1 Infected Control 12.089 8.91842 3.94E-06 0.00588 
TRINITY_DN117126_c0_g1_i1 Infected Control -6.90614 5.23935 4.35E-06 0.00588 
TRINITY_DN132196_c1_g5_i2 Infected Control -6.17813 5.87014 4.37E-06 0.00588 
TRINITY_DN130915_c0_g2_i1 Infected Control -5.45104 7.0423 7.59E-06 0.00937 
TRINITY_DN132229_c2_g1_i2 Infected Control -5.38471 6.96622 9.84E-06 0.01049 
TRINITY_DN132317_c0_g1_i6 Infected Control 11.496 8.32758 1.10E-05 0.01049 
TRINITY_DN132515_c1_g2_i1 Infected Control 11.4512 8.2831 1.18E-05 0.01049 
TRINITY_DN131369_c2_g1_i3 Infected Control -5.62186 6.00939 1.19E-05 0.01049 
TRINITY_DN132103_c4_g2_i1 Infected Control 11.4406 8.27402 1.20E-05 0.01049 
TRINITY_DN132409_c0_g1_i3 Infected Control 11.1924 8.02596 1.85E-05 0.0152 
TRINITY_DN132540_c1_g1_i1 Infected Control 11.1008 7.93602 2.16E-05 0.01685 
TRINITY_DN131476_c0_g1_i1 Infected Control -5.86606 5.0869 2.66E-05 0.01936 
TRINITY_DN132446_c0_g1_i3 Infected Control -6.32235 4.71887 2.87E-05 0.01936 
TRINITY_DN130818_c0_g1_i1 Infected Control -5.13868 6.20528 3.00E-05 0.01936 
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TRINITY_DN82050_c0_g1_i1 Infected Control -6.2914 4.69561 3.14E-05 0.01936 
TRINITY_DN131177_c0_g1_i2 Infected Control -6.2914 4.69561 3.14E-05 0.01936 
TRINITY_DN132611_c3_g1_i4 Infected Control 10.7659 7.60519 3.82E-05 0.02232 
TRINITY_DN131966_c0_g5_i1 Infected Control 10.7505 7.58745 3.93E-05 0.02232 
TRINITY_DN130520_c0_g1_i1 Infected Control -6.2116 4.62256 4.14E-05 0.02232 
TRINITY_DN132618_c0_g1_i5 Infected Control 10.7094 7.54779 4.22E-05 0.02232 
TRINITY_DN130280_c0_g1_i1 Infected Control -5.2948 5.43788 4.45E-05 0.02276 
TRINITY_DN132103_c4_g1_i1 Infected Control 10.5079 7.35019 5.97E-05 0.0295 
TRINITY_DN132516_c0_g1_i3 Infected Control 10.4439 7.28502 6.63E-05 0.03138 
TRINITY_DN132525_c3_g1_i1 Infected Control -6.02365 4.46482 6.80E-05 0.03138 
TRINITY_DN131481_c3_g1_i2 Infected Control -5.54638 4.81016 6.99E-05 0.03138 
TRINITY_DN132229_c0_g1_i1 Infected Control -4.80446 6.18883 7.32E-05 0.03189 
TRINITY_DN131949_c2_g3_i5 Infected Control 10.3499 7.19237 7.78E-05 0.03293 
TRINITY_DN132567_c0_g1_i3 Infected Control 10.2516 7.09536 9.23E-05 0.03506 
TRINITY_DN132268_c0_g2_i3 Infected Control -4.88654 5.5989 9.24E-05 0.03506 
TRINITY_DN122618_c0_g1_i1 Infected Control -5.92613 4.37849 9.41E-05 0.03506 
TRINITY_DN124731_c0_g1_i1 Infected Control -5.43817 4.72021 9.81E-05 0.03506 
TRINITY_DN132011_c4_g1_i1 Infected Control -5.43817 4.72021 9.81E-05 0.03506 
TRINITY_DN131092_c0_g4_i1 Infected Control -5.01627 5.1931 0.00011 0.03506 
TRINITY_DN131543_c0_g2_i1 Infected Control -5.88658 4.34882 0.00011 0.03506 
TRINITY_DN131256_c0_g1_i2 Infected Control 10.1744 7.02123 0.00011 0.03506 
TRINITY_DN131423_c1_g1_i2 Infected Control -5.41076 4.69675 0.00011 0.03506 
TRINITY_DN129932_c0_g1_i2 Infected Control -4.584 6.81146 0.00011 0.03506 
TRINITY_DN132054_c1_g1_i2 Infected Control 10.1485 6.99246 0.00011 0.03506 
TRINITY_DN132602_c1_g1_i4 Infected Control 10.1041 6.95072 0.00012 0.03506 
TRINITY_DN131401_c3_g2_i2 Infected Control -5.85422 4.31804 0.00012 0.03506 
TRINITY_DN128877_c0_g1_i1 Infected Control -5.85422 4.31804 0.00012 0.03506 
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TRINITY_DN132632_c8_g1_i1 Infected Control -5.85018 4.31827 0.00012 0.03506 
TRINITY_DN132469_c1_g3_i1 Infected Control 10.0589 6.90559 0.00013 0.03714 
TRINITY_DN130145_c0_g2_i4 Infected Control 10.0493 6.89684 0.00013 0.03714 
TRINITY_DN129476_c0_g1_i1 Infected Control -5.08364 4.8962 0.00013 0.03714 
TRINITY_DN132014_c0_g1_i2 Infected Control -4.47411 7.09499 0.00014 0.03717 
TRINITY_DN131885_c0_g2_i2 Infected Control 9.99825 6.84664 0.00014 0.03826 
TRINITY_DN132452_c0_g1_i4 Infected Control -4.55094 5.96423 0.00016 0.04136 
TRINITY_DN116207_c0_g1_i1 Infected Control -5.01288 4.83292 0.00017 0.04348 
TRINITY_DN76088_c0_g1_i1 Infected Control -5.7351 4.22247 0.00017 0.04348 
TRINITY_DN131431_c0_g1_i1 Infected Control 9.83462 6.68565 0.00019 0.04688 
TRINITY_DN132462_c0_g1_i1 Infected Control -5.69461 4.18904 0.00019 0.04774 
TRINITY_DN132025_c1_g1_i2 Infected Control 9.79284 6.64384 0.0002 0.04843 
TRINITY_DN128807_c0_g1_i1 Infected Control -4.69584 5.1937 0.00021 0.04843 
TRINITY_DN92141_c0_g1_i1 Infected Control 9.7804 6.63536 0.00021 0.04843 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
